| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | RNA polymerase binding | 8.31e-07 | 65 | 99 | 6 | GO:0070063 | |
| GeneOntologyMolecularFunction | basal RNA polymerase II transcription machinery binding | 9.11e-07 | 66 | 99 | 6 | GO:0001099 | |
| GeneOntologyMolecularFunction | basal transcription machinery binding | 9.11e-07 | 66 | 99 | 6 | GO:0001098 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain phosphoserine binding | 1.17e-06 | 5 | 99 | 3 | GO:1990269 | |
| GeneOntologyMolecularFunction | RNA polymerase II C-terminal domain binding | 1.90e-05 | 11 | 99 | 3 | GO:0099122 | |
| GeneOntologyMolecularFunction | phosphoserine residue binding | 2.52e-05 | 12 | 99 | 3 | GO:0050815 | |
| GeneOntologyMolecularFunction | RNA polymerase II complex binding | 4.09e-05 | 39 | 99 | 4 | GO:0000993 | |
| GeneOntologyMolecularFunction | RNA polymerase core enzyme binding | 7.25e-05 | 45 | 99 | 4 | GO:0043175 | |
| GeneOntologyMolecularFunction | chromo shadow domain binding | 3.60e-04 | 6 | 99 | 2 | GO:0070087 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | NOLC1 KDM5B URI1 TCOF1 MIS18A HIP1R YTHDC2 ZC3H18 SYNE2 AKAP13 SPEN NIPBL TNS3 PML DNMT3A | 5.75e-04 | 1160 | 99 | 15 | GO:0030674 |
| GeneOntologyMolecularFunction | molecular adaptor activity | NOLC1 DLGAP2 KDM5B URI1 TCOF1 MIS18A HIP1R YTHDC2 ZC3H18 SYNE2 AKAP13 SPEN NIPBL TNS3 PML DNMT3A | 9.96e-04 | 1356 | 99 | 16 | GO:0060090 |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | LIMA1 RPH3AL MARK3 SPTA1 KTN1 HIP1R APC TTLL4 SYNE2 MYPN PLEC PLEKHH2 PALLD HTT | 1.03e-03 | 1099 | 99 | 14 | GO:0008092 |
| GeneOntologyMolecularFunction | gamma-catenin binding | 1.55e-03 | 12 | 99 | 2 | GO:0045295 | |
| GeneOntologyBiologicalProcess | actin filament-based process | LIMA1 SPTA1 HIP1R SPECC1L ITPKA NUP155 SYNE2 MYPN IQSEC1 AKAP13 AKAP11 PLEC PLEKHH2 PALLD AGAP2 | 2.54e-05 | 912 | 98 | 15 | GO:0030029 |
| GeneOntologyBiologicalProcess | negative regulation of organelle organization | LIMA1 TBC1D30 ATRX SPTA1 HIP1R APC CEP192 SPECC1L PLEKHH2 PML | 3.19e-05 | 421 | 98 | 10 | GO:0010639 |
| GeneOntologyBiologicalProcess | maintenance of sister chromatid cohesion | 3.64e-05 | 14 | 98 | 3 | GO:0034086 | |
| GeneOntologyBiologicalProcess | protein depolymerization | 6.48e-05 | 144 | 98 | 6 | GO:0051261 | |
| GeneOntologyBiologicalProcess | negative regulation of protein depolymerization | 6.61e-05 | 89 | 98 | 5 | GO:1901880 | |
| GeneOntologyBiologicalProcess | keratinocyte development | 6.74e-05 | 17 | 98 | 3 | GO:0003334 | |
| GeneOntologyBiologicalProcess | actin cytoskeleton organization | LIMA1 SPTA1 HIP1R SPECC1L ITPKA MYPN IQSEC1 AKAP13 AKAP11 PLEC PLEKHH2 PALLD AGAP2 | 1.09e-04 | 803 | 98 | 13 | GO:0030036 |
| GeneOntologyBiologicalProcess | negative regulation of actin filament depolymerization | 1.09e-04 | 52 | 98 | 4 | GO:0030835 | |
| GeneOntologyBiologicalProcess | negative regulation of protein-containing complex disassembly | 1.15e-04 | 100 | 98 | 5 | GO:0043242 | |
| GeneOntologyBiologicalProcess | regulation of protein depolymerization | 1.45e-04 | 105 | 98 | 5 | GO:1901879 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | LIMA1 TBC1D30 ATRX SPTA1 HIP1R APC CEP192 SPECC1L TBC1D22A SYNE2 SGO2 AKAP13 TMEM102 CDK11B PLEKHH2 HTT PML | 1.82e-04 | 1342 | 98 | 17 | GO:0033043 |
| GeneOntologyBiologicalProcess | regulation of actin filament depolymerization | 2.03e-04 | 61 | 98 | 4 | GO:0030834 | |
| GeneOntologyBiologicalProcess | actin filament depolymerization | 2.76e-04 | 66 | 98 | 4 | GO:0030042 | |
| GeneOntologyBiologicalProcess | negative regulation of Rho protein signal transduction | 2.80e-04 | 27 | 98 | 3 | GO:0035024 | |
| GeneOntologyBiologicalProcess | sister chromatid cohesion | 2.92e-04 | 67 | 98 | 4 | GO:0007062 | |
| GeneOntologyBiologicalProcess | negative regulation of cytoskeleton organization | 3.29e-04 | 194 | 98 | 6 | GO:0051494 | |
| GeneOntologyBiologicalProcess | uterus morphogenesis | 3.31e-04 | 6 | 98 | 2 | GO:0061038 | |
| GeneOntologyBiologicalProcess | negative regulation of supramolecular fiber organization | 3.57e-04 | 197 | 98 | 6 | GO:1902904 | |
| GeneOntologyBiologicalProcess | developmental growth | KDM5B TCF7L2 ACACB ATRX RBBP6 DUSP6 APC RYK RTF1 ADRA1B AKAP13 PLEC NIPBL | 3.72e-04 | 911 | 98 | 13 | GO:0048589 |
| GeneOntologyBiologicalProcess | chromosome organization | TCF7L2 ATRX MIS18A APC CEP192 NUP155 UHRF1 SGO2 CDK11B NIPBL PML | 4.12e-04 | 686 | 98 | 11 | GO:0051276 |
| GeneOntologyCellularComponent | chromosomal region | 1.62e-04 | 421 | 98 | 9 | GO:0098687 | |
| GeneOntologyCellularComponent | nuclear body | NOLC1 TCF7L2 ATRX RBBP6 CDK12 ZC3H18 THOC2 MSANTD1 PABPN1 SGO2 PLEKHH2 TOPORS PML | 3.01e-04 | 903 | 98 | 13 | GO:0016604 |
| GeneOntologyCellularComponent | chromosome, centromeric region | 3.22e-04 | 276 | 98 | 7 | GO:0000775 | |
| GeneOntologyCellularComponent | microtubule organizing center | LEO1 TBC1D30 RBBP6 CENPU APC TACC2 CEP192 SPECC1L TTLL4 AKAP11 CDC25B TOPORS HTT | 3.56e-04 | 919 | 98 | 13 | GO:0005815 |
| GeneOntologyCellularComponent | Cdc73/Paf1 complex | 4.50e-04 | 7 | 98 | 2 | GO:0016593 | |
| GeneOntologyCellularComponent | cortical actin cytoskeleton | 9.64e-04 | 93 | 98 | 4 | GO:0030864 | |
| Domain | Znf_FYVE_PHD | 1.25e-04 | 147 | 98 | 6 | IPR011011 | |
| Domain | ADD | 1.62e-04 | 4 | 98 | 2 | IPR025766 | |
| Domain | ADD | 1.62e-04 | 4 | 98 | 2 | PS51533 | |
| Domain | Spectrin_repeat | 4.64e-04 | 29 | 98 | 3 | IPR002017 | |
| Domain | - | 5.88e-04 | 449 | 98 | 9 | 3.30.40.10 | |
| Domain | Spectrin/alpha-actinin | 6.22e-04 | 32 | 98 | 3 | IPR018159 | |
| Domain | SPEC | 6.22e-04 | 32 | 98 | 3 | SM00150 | |
| Domain | Znf_RING/FYVE/PHD | 6.88e-04 | 459 | 98 | 9 | IPR013083 | |
| Domain | RING | 1.13e-03 | 305 | 98 | 7 | SM00184 | |
| Domain | FYVE_2 | 1.45e-03 | 11 | 98 | 2 | PF02318 | |
| Domain | Znf_RING | 1.65e-03 | 326 | 98 | 7 | IPR001841 | |
| Domain | RABBD | 1.74e-03 | 12 | 98 | 2 | PS50916 | |
| Domain | Rab_BD | 1.74e-03 | 12 | 98 | 2 | IPR010911 | |
| Domain | CH | 4.84e-03 | 65 | 98 | 3 | SM00033 | |
| Pubmed | NOLC1 LEO1 TCOF1 RBBP6 CDK12 BACH1 APC TACC2 RAB11FIP1 THOC2 GTF2F1 GTF3C1 MYPN UHRF1 ZNF740 AKAP13 CDK11B SPEN NIPBL PALLD | 1.65e-17 | 503 | 99 | 20 | 16964243 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | NOLC1 KDM5B LIMA1 MARK3 BACH1 APC CEP192 RAB11FIP1 MDM4 LYST SYNE2 IQSEC1 AKAP13 AKAP11 BOD1L1 TMEM102 PROSER2 PLEC CDC25B PALLD TNS3 PML | 3.34e-15 | 861 | 99 | 22 | 36931259 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | NOLC1 LIMA1 LEO1 ATRX TCOF1 RBBP6 CDK12 BACH1 YTHDC2 ZC3H18 THOC2 PAXBP1 GTF3C1 IQSEC1 PROSER2 CDK11B PLEC TOPORS SPEN NIPBL | 5.75e-14 | 774 | 99 | 20 | 15302935 |
| Pubmed | NOLC1 LEO1 ATRX RBBP6 CDK12 WDR70 ZC3H18 THOC2 CMAS RTF1 GTF2F1 NUP155 GTF3C1 PABPN1 UHRF1 BOD1L1 CDK11B PLEC NIPBL PML | 7.97e-12 | 1014 | 99 | 20 | 32416067 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | NOLC1 RBBP6 CDK12 MARK3 KTN1 CENPU YTHDC2 ZCCHC17 TACC2 THOC2 CMAS ZC3H7A NUP155 GTF3C1 PABPN1 UHRF1 SGO2 | 5.05e-11 | 759 | 99 | 17 | 35915203 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | NOLC1 TCF7L2 LEO1 ATRX TCOF1 RBBP6 SPTA1 KTN1 BACH1 ZC3H18 THOC2 CMAS ZNF276 PAXBP1 GTF3C1 PABPN1 UHRF1 ZNF740 NKTR SPEN NIPBL | 8.31e-11 | 1294 | 99 | 21 | 30804502 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | LEO1 ATRX TCOF1 RBBP6 APC TACC2 ZC3H18 CEP192 MDM4 ZC3H7A GTF2F1 CDK11B TOPORS SPEN PML | 1.29e-10 | 588 | 99 | 15 | 38580884 |
| Pubmed | NOLC1 LEO1 RBBP6 CDK12 ZC3H18 PAXBP1 UHRF1 BOD1L1 CDK11B SPEN DNMT3A | 1.60e-10 | 251 | 99 | 11 | 31076518 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | NOLC1 KDM5B TCOF1 RBBP6 CDK12 APC ZCCHC17 ZC3H18 THOC2 CMAS PAXBP1 GTF3C1 PABPN1 IQSEC1 CDK11B PLEC SPEN NIPBL DNMT3A | 2.03e-10 | 1082 | 99 | 19 | 38697112 |
| Pubmed | The in vivo Interaction Landscape of Histones H3.1 and H3.3. | TCF7L2 ATRX WDR70 ZC3H18 CMAS GTF3C1 ATAD2B UHRF1 SGO2 BOD1L1 CDK11B SPEN NIPBL DNMT3A BRWD1 | 2.04e-10 | 608 | 99 | 15 | 36089195 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | ATRX RBBP6 CDK12 WDR70 YTHDC2 ZC3H18 THOC2 RTF1 BOD1L1 CDK11B SPEN | 5.70e-10 | 283 | 99 | 11 | 30585729 |
| Pubmed | Multiplexed kinase interactome profiling quantifies cellular network activity and plasticity. | NOLC1 SLK LEO1 ATRX CDK12 MARK3 CEP192 CMAS LYST RTF1 GTF3C1 AKAP11 NKTR CDK11B PLEC PALLD TNS3 | 8.07e-10 | 910 | 99 | 17 | 36736316 |
| Pubmed | NOLC1 KDM5B ATRX RBBP6 ZC3H18 CMAS PAXBP1 GTF3C1 UHRF1 BOD1L1 CDK11B SPEN PML | 8.93e-10 | 469 | 99 | 13 | 27634302 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | NOLC1 LIMA1 SLK ACACB ATRX TCOF1 RBBP6 CDK12 KTN1 WDR70 YTHDC2 TACC2 THOC2 BOD1L1 NIPBL PALLD PML | 1.19e-09 | 934 | 99 | 17 | 33916271 |
| Pubmed | LIMA1 SLK TCOF1 RBBP6 CDK12 KTN1 SPECC1L THOC2 GTF3C1 BOD1L1 SPEN PALLD HTT | 5.89e-09 | 549 | 99 | 13 | 38280479 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | NOLC1 RBBP6 CDK12 WDR70 YTHDC2 ZCCHC17 ZC3H18 AKAP13 SPEN PALLD TNS3 | 7.22e-09 | 361 | 99 | 11 | 26167880 |
| Pubmed | HEY1 functions are regulated by its phosphorylation at Ser-68. | 1.10e-08 | 95 | 99 | 7 | 27129302 | |
| Pubmed | NOLC1 LIMA1 LEO1 TCOF1 RBBP6 CDK12 WDR70 RTF1 GTF2F1 PAXBP1 PABPN1 BOD1L1 | 2.32e-08 | 506 | 99 | 12 | 30890647 | |
| Pubmed | A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. | NOLC1 URI1 LEO1 TCOF1 BACH1 WDR70 SNRK RAB11FIP1 ZC3H7A GTF2F1 TTLL4 MYPN IQSEC1 PROSER2 CDC25B TNS3 | 3.93e-08 | 1038 | 99 | 16 | 26673895 |
| Pubmed | TBC1D30 ATRX RBBP6 CDK12 MARK3 KTN1 HIP1R APC YTHDC2 SPECC1L RAB11FIP1 CMAS ZC3H7A GTF2F1 PAXBP1 ZKSCAN1 UQCRFS1 SPEN NIPBL | 3.97e-08 | 1497 | 99 | 19 | 31527615 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | PRUNE2 DLGAP2 TCF7L2 ACACB TCOF1 RBBP6 MDM4 NUP155 AKAP13 PLEC SPEN | 4.32e-08 | 430 | 99 | 11 | 35044719 |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | NOLC1 ATRX RBBP6 CDK12 KTN1 ZC3H18 THOC2 PAXBP1 ATAD2B SGO2 BOD1L1 CDK11B SPEN NIPBL PML | 8.46e-08 | 954 | 99 | 15 | 36373674 |
| Pubmed | Ubiquitin-Independent Disassembly by a p97 AAA-ATPase Complex Drives PP1 Holoenzyme Formation. | 8.81e-08 | 361 | 99 | 10 | 30344098 | |
| Pubmed | ATG5 is required for B cell polarization and presentation of particulate antigens. | LIMA1 RBBP6 CDK12 KTN1 WDR70 YTHDC2 ZCCHC17 SPECC1L RAB11FIP1 PABPN1 AKAP13 NKTR PLEC | 1.02e-07 | 701 | 99 | 13 | 30196744 |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM5B SLK TCOF1 MARK3 KTN1 WDR70 CENPU APC YTHDC2 ZC3H18 CEP192 NUP155 SYTL4 PLEC CDC25B | 1.65e-07 | 1005 | 99 | 15 | 19615732 |
| Pubmed | CDK12 KTN1 WDR70 APC ZC3H7A GTF2F1 SYTL4 TBC1D22A TTLL4 AKAP13 BOD1L1 CDK11B TNS3 | 1.71e-07 | 733 | 99 | 13 | 34672954 | |
| Pubmed | SLK LEO1 ATRX CDK12 APC YTHDC2 GTF2F1 NUP155 GTF3C1 AKAP13 CDC25B PALLD | 3.45e-07 | 650 | 99 | 12 | 38777146 | |
| Pubmed | NOLC1 ATRX TCOF1 RBBP6 RAB11FIP1 THOC2 PABPN1 UHRF1 SGO2 PLEC NIPBL PML | 3.57e-07 | 652 | 99 | 12 | 31180492 | |
| Pubmed | NOLC1 TCOF1 YTHDC2 ZC3H18 THOC2 NUP155 GTF3C1 ATAD2B SYNE2 PLEC SPEN NIPBL | 3.63e-07 | 653 | 99 | 12 | 22586326 | |
| Pubmed | The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. | 4.45e-07 | 6 | 99 | 3 | 3291115 | |
| Pubmed | 4.45e-07 | 6 | 99 | 3 | 8346215 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | NOLC1 SLK URI1 LEO1 TCOF1 KTN1 TACC2 ZC3H18 RTF1 GTF2F1 PAXBP1 NUP155 SYNE2 AKAP13 PLEC NIPBL PALLD | 4.89e-07 | 1415 | 99 | 17 | 28515276 |
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | NOLC1 LIMA1 TCOF1 RBBP6 MARK3 ZCCHC17 SPECC1L THOC2 CMAS NUP155 PABPN1 UHRF1 CDK11B PLEC | 5.10e-07 | 949 | 99 | 14 | 36574265 |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | 5.42e-07 | 440 | 99 | 10 | 34244565 | |
| Pubmed | NOLC1 LIMA1 SLK TCF7L2 ACACB ATRX RBBP6 ZC3H18 CEP192 VSX1 GTF3C1 ZKSCAN1 PABPN1 SYNE2 SPEN NIPBL PML | 5.60e-07 | 1429 | 99 | 17 | 35140242 | |
| Pubmed | NOLC1 LIMA1 CCDC185 LEO1 ACACB ATRX SPTA1 KTN1 LYST ZC3H7A GTF3C1 SYNE2 BOD1L1 PLEC SPEN NIPBL AGAP2 | 6.35e-07 | 1442 | 99 | 17 | 35575683 | |
| Pubmed | 6.78e-07 | 451 | 99 | 10 | 30033366 | ||
| Pubmed | Two putative protein-tyrosine kinases identified by application of the polymerase chain reaction. | 7.77e-07 | 7 | 99 | 3 | 2466296 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | NOLC1 TCOF1 MIS18A THOC2 CMAS RYK RTF1 GTF3C1 PABPN1 UHRF1 BOD1L1 CDK11B PLEC PML | 8.32e-07 | 989 | 99 | 14 | 36424410 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | NOLC1 BACH1 CENPU APC TACC2 CEP192 GTF2F1 PAXBP1 NUP155 GTF3C1 SYTL4 MYPN SGO2 CDC25B NIPBL | 9.55e-07 | 1155 | 99 | 15 | 20360068 |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | PRUNE2 URI1 TCF7L2 RPH3AL ATRX MARK3 WDR70 CEP192 WDR25 MDM4 ADGRG6 GTF3C1 TBC1D22A AKAP13 BOD1L1 ANKRD12 HTT | 9.87e-07 | 1489 | 99 | 17 | 28611215 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | SLK KTN1 APC YTHDC2 SPECC1L ZC3H7A SYTL4 AKAP13 PLEC SPEN PALLD TNS3 | 1.07e-06 | 724 | 99 | 12 | 36232890 |
| Pubmed | A novel mechanism for the transcriptional regulation of Wnt signaling in development. | 1.24e-06 | 8 | 99 | 3 | 21856776 | |
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 1.27e-06 | 190 | 99 | 7 | 15161933 | |
| Pubmed | 1.86e-06 | 9 | 99 | 3 | 15923622 | ||
| Pubmed | 2.39e-06 | 209 | 99 | 7 | 36779422 | ||
| Pubmed | NOLC1 ATRX APC TACC2 CEP192 THOC2 PAXBP1 TTLL4 MYPN BOD1L1 ANKRD12 PLEC PML BRWD1 | 2.43e-06 | 1084 | 99 | 14 | 11544199 | |
| Pubmed | NOLC1 LIMA1 TCF7L2 TCOF1 RBBP6 MARK3 KTN1 APC SPECC1L THOC2 CMAS PAXBP1 UQCRFS1 TOPORS TNS3 | 2.45e-06 | 1247 | 99 | 15 | 27684187 | |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | NOLC1 SLK ATRX TCOF1 KTN1 YTHDC2 THOC2 PAXBP1 NUP155 GTF3C1 PABPN1 UHRF1 SGO2 BOD1L1 SPEN NIPBL | 2.65e-06 | 1425 | 99 | 16 | 30948266 |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | NOLC1 LIMA1 RBBP6 MARK3 YTHDC2 ZC3H18 SPECC1L THOC2 CMAS NUP155 GTF3C1 PLEC TOPORS SPEN PML | 2.70e-06 | 1257 | 99 | 15 | 36526897 |
| Pubmed | NOLC1 TCOF1 ABCA12 RBBP6 YTHDC2 ZC3H18 RAB11FIP1 CMAS IQSEC1 ZNF740 VAX2 TOPORS PML BRWD1 | 3.40e-06 | 1116 | 99 | 14 | 31753913 | |
| Pubmed | NOLC1 ATRX TCOF1 MARK3 KTN1 BACH1 CEP192 RAB11FIP1 CMAS ZC3H7A PAXBP1 NUP155 SYNE2 AKAP13 AKAP11 PML | 4.56e-06 | 1487 | 99 | 16 | 33957083 | |
| Pubmed | 4.90e-06 | 86 | 99 | 5 | 37253089 | ||
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | NOLC1 KTN1 WDR70 HIP1R CMAS ZC3H7A NUP155 GTF3C1 PABPN1 IQSEC1 AKAP13 PLEC NIPBL PALLD TNS3 | 6.57e-06 | 1353 | 99 | 15 | 29467282 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | NOLC1 LIMA1 TCOF1 YTHDC2 SPECC1L THOC2 NUP155 GTF3C1 SYNE2 UHRF1 PLEC SPEN NIPBL | 6.91e-06 | 1024 | 99 | 13 | 24711643 |
| Pubmed | NOLC1 TCOF1 RBBP6 CDK12 HIP1R YTHDC2 ZC3H18 THOC2 PAXBP1 PABPN1 SPEN | 7.73e-06 | 731 | 99 | 11 | 29298432 | |
| Pubmed | 7.73e-06 | 250 | 99 | 7 | 33536335 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 28901428 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 28976982 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 37205756 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 9041176 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 30273442 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 22945642 | ||
| Pubmed | 8.02e-06 | 2 | 99 | 2 | 28445727 | ||
| Pubmed | 9.20e-06 | 360 | 99 | 8 | 33111431 | ||
| Pubmed | 9.93e-06 | 15 | 99 | 3 | 21406692 | ||
| Pubmed | 1.18e-05 | 103 | 99 | 5 | 32744500 | ||
| Pubmed | DLGAP2 LIMA1 SLK MARK3 SPTA1 KTN1 APC YTHDC2 SPECC1L CMAS ITPKA IQSEC1 UQCRFS1 PLEC AGAP2 | 1.28e-05 | 1431 | 99 | 15 | 37142655 | |
| Pubmed | 1.34e-05 | 272 | 99 | 7 | 31010829 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | CDK12 WDR70 HIP1R CEP192 ZBTB42 LYST PPP1R26 ZNF276 TTLL4 AKAP13 PLEC SPEN HTT | 1.55e-05 | 1105 | 99 | 13 | 35748872 |
| Pubmed | The contribution of de novo coding mutations to autism spectrum disorder. | 1.77e-05 | 18 | 99 | 3 | 25363768 | |
| Pubmed | DLGAP2 LIMA1 SLK TCOF1 KTN1 APC SPECC1L ZKSCAN1 SYNE2 IQSEC1 NIPBL AGAP2 | 1.92e-05 | 963 | 99 | 12 | 28671696 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | NOLC1 TCOF1 RBBP6 YTHDC2 ZCCHC17 ZC3H18 ZC3H7A GTF2F1 PABPN1 CDK11B SPEN | 1.94e-05 | 807 | 99 | 11 | 22681889 |
| Pubmed | Complementary proteomics strategies capture an ataxin-1 interactome in Neuro-2a cells. | LEO1 ACACB TCOF1 RBBP6 ZC3H18 NUP155 CDK11B UQCRFS1 PHOX2B SPEN | 2.06e-05 | 665 | 99 | 10 | 30457570 |
| Pubmed | NOLC1 DLGAP2 ACACB KTN1 BACH1 HIP1R APC SNRK TACC2 CMAS IQSEC1 PLEC AGAP2 | 2.12e-05 | 1139 | 99 | 13 | 36417873 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NOLC1 ACACB TCOF1 RBBP6 MIS18A ZCCHC17 THOC2 PAXBP1 IQSEC1 NKTR CDK11B UQCRFS1 PLEC NIPBL | 2.21e-05 | 1318 | 99 | 14 | 30463901 |
| Pubmed | Interactome Rewiring Following Pharmacological Targeting of BET Bromodomains. | 2.22e-05 | 533 | 99 | 9 | 30554943 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 15252119 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 11063258 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 24324066 | ||
| Pubmed | Inhibition of DNA Methyltransferases Blocks Mutant Huntingtin-Induced Neurotoxicity. | 2.40e-05 | 3 | 99 | 2 | 27516062 | |
| Pubmed | Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway. | 2.40e-05 | 3 | 99 | 2 | 10027409 | |
| Pubmed | BNIP2 extra long inhibits RhoA and cellular transformation by Lbc RhoGEF via its BCH domain. | 2.40e-05 | 3 | 99 | 2 | 18445682 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 28341773 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 24960609 | ||
| Pubmed | Inhibition of intestinal tumor formation by deletion of the DNA methyltransferase 3a. | 2.40e-05 | 3 | 99 | 2 | 24837369 | |
| Pubmed | Myogenic differentiation triggers PML nuclear body loss and DAXX relocalization to chromocentres. | 2.40e-05 | 3 | 99 | 2 | 28358373 | |
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 30530687 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 15604408 | ||
| Pubmed | 2.40e-05 | 3 | 99 | 2 | 17234755 | ||
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.00e-05 | 208 | 99 | 6 | 33230847 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | LIMA1 SLK LEO1 THOC2 MTERF4 GTF2F1 BOD1L1 UQCRFS1 PLEC NIPBL BRWD1 | 3.01e-05 | 847 | 99 | 11 | 35235311 |
| Pubmed | Comparative interactome analysis of α-arrestin families in human and Drosophila. | 3.28e-05 | 313 | 99 | 7 | 38270169 | |
| Pubmed | Interlaboratory reproducibility of large-scale human protein-complex analysis by standardized AP-MS. | 3.39e-05 | 432 | 99 | 8 | 23455922 | |
| Pubmed | TCOF1 CDK12 MARK3 KTN1 ZCCHC17 SPECC1L THOC2 PAXBP1 PABPN1 IQSEC1 UHRF1 NKTR CDK11B PLEC | 3.40e-05 | 1371 | 99 | 14 | 36244648 | |
| Pubmed | RBBP6 CDK12 YTHDC2 ZC3H18 THOC2 PAXBP1 GTF3C1 PABPN1 NKTR CDK11B | 3.72e-05 | 713 | 99 | 10 | 29802200 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | TCF7L2 TCOF1 RBBP6 CDK12 KTN1 THOC2 NUP155 ZKSCAN1 IQSEC1 ZNF740 PLEC TOPORS PML | 3.74e-05 | 1203 | 99 | 13 | 29180619 |
| Pubmed | 4.25e-05 | 446 | 99 | 8 | 24255178 | ||
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.40e-05 | 582 | 99 | 9 | 20467437 | |
| Pubmed | 4.65e-05 | 225 | 99 | 6 | 12168954 | ||
| Interaction | YWHAG interactions | NOLC1 KDM5B LIMA1 SLK CDK12 MARK3 APC CEP192 SPECC1L RAB11FIP1 MDM4 LYST SYNE2 IQSEC1 AKAP13 AKAP11 BOD1L1 NKTR TMEM102 PROSER2 CDK11B CDC25B TNS3 HTT | 5.53e-09 | 1248 | 99 | 24 | int:YWHAG |
| Interaction | SFN interactions | NOLC1 LIMA1 SLK MARK3 BACH1 APC ZC3H18 CEP192 RAB11FIP1 MDM4 LYST AKAP13 AKAP11 PLEC CDC25B PALLD TNS3 HTT | 6.60e-09 | 692 | 99 | 18 | int:SFN |
| Interaction | CSNK2B interactions | NOLC1 TCF7L2 LEO1 ATRX TCOF1 APC SNRK ZCCHC17 ZC3H18 VSX1 LYST ATAD2B NKTR CDK11B CDC25B TOPORS PML | 9.50e-09 | 625 | 99 | 17 | int:CSNK2B |
| Interaction | YWHAH interactions | NOLC1 KDM5B LIMA1 MARK3 APC CEP192 SPECC1L RAB11FIP1 MDM4 LYST SYNE2 AKAP13 AKAP11 BOD1L1 NKTR TMEM102 PROSER2 PLEC CDC25B PALLD TNS3 HTT | 1.40e-08 | 1102 | 99 | 22 | int:YWHAH |
| Interaction | YWHAZ interactions | NOLC1 KDM5B LIMA1 SLK MARK3 SPTA1 HIP1R APC TACC2 ZC3H18 CEP192 RAB11FIP1 MDM4 LYST ITPKA SYNE2 AKAP13 AKAP11 TMEM102 CDK11B PLEC CDC25B HTT PML | 1.61e-08 | 1319 | 99 | 24 | int:YWHAZ |
| Interaction | CENPA interactions | LEO1 ATRX MIS18A CENPU THOC2 RTF1 GTF2F1 GTF3C1 UHRF1 SGO2 NIPBL DNMT3A BRWD1 | 4.05e-08 | 377 | 99 | 13 | int:CENPA |
| Interaction | HECTD1 interactions | NOLC1 RBBP6 CDK12 MARK3 KTN1 CENPU APC YTHDC2 ZCCHC17 TACC2 THOC2 CMAS ZC3H7A PAXBP1 NUP155 GTF3C1 PABPN1 UHRF1 SGO2 TNS3 | 5.35e-08 | 984 | 99 | 20 | int:HECTD1 |
| Interaction | TERF2IP interactions | LEO1 RBBP6 CDK12 WDR70 ZC3H18 THOC2 RTF1 GTF2F1 PAXBP1 GTF3C1 BOD1L1 SPEN NIPBL PML DNMT3A | 7.85e-08 | 552 | 99 | 15 | int:TERF2IP |
| Interaction | YWHAQ interactions | NOLC1 KDM5B LIMA1 SLK MARK3 SPTA1 APC CEP192 SPECC1L RAB11FIP1 MDM4 LYST PABPN1 AKAP13 AKAP11 TMEM102 CDK11B PLEC CDC25B TNS3 HTT | 8.97e-08 | 1118 | 99 | 21 | int:YWHAQ |
| Interaction | CSNK2A1 interactions | NOLC1 TCF7L2 LEO1 ATRX TCOF1 CDK12 APC SNRK ZCCHC17 ZC3H18 VSX1 LYST RTF1 GTF2F1 NKTR CDK11B CDC25B HTT PML | 1.72e-07 | 956 | 99 | 19 | int:CSNK2A1 |
| Interaction | NUP43 interactions | LEO1 ACACB RBBP6 CDK12 APC ZC3H18 RTF1 PAXBP1 ATAD2B SYNE2 BOD1L1 NKTR CDK11B SPEN NIPBL | 3.87e-07 | 625 | 99 | 15 | int:NUP43 |
| Interaction | UHRF2 interactions | 6.25e-07 | 200 | 99 | 9 | int:UHRF2 | |
| Interaction | DDX23 interactions | NOLC1 SLK LEO1 TCOF1 RBBP6 CDK12 WDR70 ZC3H18 THOC2 RTF1 GTF2F1 PAXBP1 NKTR | 6.48e-07 | 480 | 99 | 13 | int:DDX23 |
| Interaction | MYCN interactions | NOLC1 KDM5B LIMA1 TCOF1 RBBP6 CDK12 MARK3 KTN1 CENPU YTHDC2 ZCCHC17 ZC3H18 THOC2 LYST PAXBP1 NUP155 GTF3C1 PABPN1 UHRF1 AKAP13 PLEKHH2 DNMT3A | 6.49e-07 | 1373 | 99 | 22 | int:MYCN |
| Interaction | ATG16L1 interactions | LIMA1 ACACB RBBP6 CDK12 MIS18A KTN1 BACH1 WDR70 APC YTHDC2 ZCCHC17 CEP192 SPECC1L RAB11FIP1 PABPN1 TTLL4 AKAP13 NKTR PLEC TNS3 | 7.56e-07 | 1161 | 99 | 20 | int:ATG16L1 |
| Interaction | MECP2 interactions | NOLC1 KDM5B ATRX TCOF1 RBBP6 CDK12 APC ZCCHC17 ZC3H18 THOC2 CMAS PAXBP1 GTF3C1 PABPN1 IQSEC1 NKTR CDK11B PLEC SPEN NIPBL DNMT3A | 9.18e-07 | 1287 | 99 | 21 | int:MECP2 |
| Interaction | PAF1 interactions | 1.10e-06 | 214 | 99 | 9 | int:PAF1 | |
| Interaction | PPP1CA interactions | LIMA1 SLK URI1 LEO1 APC ZC3H18 CEP192 MDM4 PPP1R26 ZC3H7A MYPN PCIF1 AKAP11 HTT AGAP2 | 1.49e-06 | 696 | 99 | 15 | int:PPP1CA |
| Interaction | YWHAB interactions | KDM5B LIMA1 SLK URI1 MARK3 APC CEP192 RAB11FIP1 MDM4 LYST TBC1D22A AKAP13 AKAP11 CDK11B CDC25B TNS3 HTT AGAP2 | 1.94e-06 | 1014 | 99 | 18 | int:YWHAB |
| Interaction | SRPK2 interactions | NOLC1 TCOF1 RBBP6 CDK12 WDR70 YTHDC2 ZCCHC17 ZC3H18 RTF1 PAXBP1 AKAP13 NKTR SPEN PALLD TNS3 | 2.15e-06 | 717 | 99 | 15 | int:SRPK2 |
| Interaction | CSNK2A2 interactions | NOLC1 TCF7L2 ATRX TCOF1 ZCCHC17 ZC3H18 VSX1 LYST RTF1 GTF3C1 SGO2 NKTR CDK11B HTT AGAP2 | 2.19e-06 | 718 | 99 | 15 | int:CSNK2A2 |
| Interaction | XRCC6 interactions | TCF7L2 ATRX RBBP6 CDK12 SPTA1 WDR70 CENPU YTHDC2 ZC3H18 THOC2 RYK RTF1 GTF2F1 BOD1L1 CDK11B SPEN HTT | 2.55e-06 | 928 | 99 | 17 | int:XRCC6 |
| Interaction | CENPK interactions | 4.72e-06 | 88 | 99 | 6 | int:CENPK | |
| Interaction | BCLAF1 interactions | NOLC1 TCOF1 RBBP6 CDK12 MARK3 ZC3H18 THOC2 PABPN1 CDK11B SPEN | 4.79e-06 | 327 | 99 | 10 | int:BCLAF1 |
| Interaction | POLR1G interactions | NOLC1 URI1 LEO1 TCOF1 WDR70 ZC3H18 RTF1 GTF2F1 GTF3C1 SGO2 NIPBL DNMT3A | 4.97e-06 | 489 | 99 | 12 | int:POLR1G |
| Interaction | NAA40 interactions | NOLC1 LIMA1 SLK ACACB ATRX TCOF1 RBBP6 CDK12 KTN1 WDR70 YTHDC2 TACC2 THOC2 BOD1L1 NIPBL PALLD PML | 5.15e-06 | 978 | 99 | 17 | int:NAA40 |
| Interaction | ZC3H18 interactions | NOLC1 LEO1 TCOF1 RBBP6 CDK12 WDR70 HIP1R YTHDC2 ZC3H18 THOC2 RTF1 PAXBP1 PABPN1 NKTR TOPORS SPEN | 5.51e-06 | 877 | 99 | 16 | int:ZC3H18 |
| Interaction | H3C3 interactions | ATRX WDR70 ZC3H18 CMAS GTF3C1 ATAD2B UHRF1 SGO2 BOD1L1 SPEN NIPBL DNMT3A | 5.62e-06 | 495 | 99 | 12 | int:H3C3 |
| Interaction | HEY1 interactions | 5.87e-06 | 140 | 99 | 7 | int:HEY1 | |
| Interaction | ACTC1 interactions | NOLC1 LIMA1 LEO1 TCOF1 RBBP6 CDK12 WDR70 RTF1 GTF2F1 PAXBP1 PABPN1 SYNE2 BOD1L1 PLEC | 7.35e-06 | 694 | 99 | 14 | int:ACTC1 |
| Interaction | EPB41L3 interactions | 7.81e-06 | 272 | 99 | 9 | int:EPB41L3 | |
| Interaction | IK interactions | 1.10e-05 | 215 | 99 | 8 | int:IK | |
| Interaction | ARHGAP42 interactions | 1.14e-05 | 60 | 99 | 5 | int:ARHGAP42 | |
| Interaction | ATXN1 interactions | LEO1 ACACB TCOF1 RBBP6 DUSP6 ZC3H18 VSX1 MTERF4 ZNF276 NUP155 SYNE2 UHRF1 CDK11B UQCRFS1 PHOX2B SPEN PML | 1.14e-05 | 1039 | 99 | 17 | int:ATXN1 |
| Interaction | SLU7 interactions | 1.19e-05 | 156 | 99 | 7 | int:SLU7 | |
| Interaction | PPP1CC interactions | LIMA1 URI1 LEO1 CDK12 APC TACC2 ZC3H18 SPECC1L RAB11FIP1 MDM4 MYPN AKAP13 AKAP11 PLEC | 1.47e-05 | 738 | 99 | 14 | int:PPP1CC |
| Interaction | RAD18 interactions | NOLC1 LIMA1 LEO1 RBBP6 CDK12 ZC3H18 PAXBP1 UHRF1 CDK11B SPEN DNMT3A | 1.52e-05 | 457 | 99 | 11 | int:RAD18 |
| Interaction | CDK12 interactions | 1.68e-05 | 228 | 99 | 8 | int:CDK12 | |
| Interaction | H3-3A interactions | TCF7L2 ATRX WDR70 CMAS GTF3C1 ATAD2B UHRF1 BOD1L1 CDK11B SPEN NIPBL PML DNMT3A BRWD1 | 1.73e-05 | 749 | 99 | 14 | int:H3-3A |
| Interaction | SORBS2 interactions | 1.80e-05 | 111 | 99 | 6 | int:SORBS2 | |
| Interaction | H2BC8 interactions | ATRX WDR70 CMAS RTF1 GTF2F1 GTF3C1 UHRF1 SGO2 AKAP11 SPEN NIPBL DNMT3A | 2.55e-05 | 576 | 99 | 12 | int:H2BC8 |
| Interaction | DENND2D interactions | 2.86e-05 | 36 | 99 | 4 | int:DENND2D | |
| Interaction | BRD3 interactions | NOLC1 ABCA12 RBBP6 RAB11FIP1 THOC2 GTF3C1 PABPN1 UHRF1 ZNF740 TOPORS NIPBL | 3.10e-05 | 494 | 99 | 11 | int:BRD3 |
| Interaction | NOLC1 interactions | 3.20e-05 | 325 | 99 | 9 | int:NOLC1 | |
| Interaction | SUPT5H interactions | 3.25e-05 | 408 | 99 | 10 | int:SUPT5H | |
| Interaction | YWHAE interactions | NOLC1 KDM5B LIMA1 CDK12 MARK3 KTN1 APC TACC2 ZC3H18 RAB11FIP1 MDM4 LYST AKAP13 AKAP11 TMEM102 CDK11B CDC25B HTT | 3.60e-05 | 1256 | 99 | 18 | int:YWHAE |
| Interaction | SRSF6 interactions | RBBP6 CDK12 CENPU YTHDC2 ZCCHC17 ZC3H18 PAXBP1 NKTR CDK11B TOPORS SPEN | 3.66e-05 | 503 | 99 | 11 | int:SRSF6 |
| Interaction | LLGL2 interactions | 5.00e-05 | 133 | 99 | 6 | int:LLGL2 | |
| Interaction | MAGEB2 interactions | 5.56e-05 | 349 | 99 | 9 | int:MAGEB2 | |
| Interaction | RPL15 interactions | NOLC1 CDK12 CENPU YTHDC2 ZC3H18 SPECC1L MDM4 GTF2F1 NKTR TOPORS PML | 5.86e-05 | 530 | 99 | 11 | int:RPL15 |
| Interaction | SNRPC interactions | LEO1 RBBP6 CDK12 ZC3H18 THOC2 PAXBP1 PABPN1 NKTR CDC25B SPEN | 6.12e-05 | 440 | 99 | 10 | int:SNRPC |
| Interaction | ZNF816 interactions | 6.15e-05 | 16 | 99 | 3 | int:ZNF816 | |
| Interaction | PARP1 interactions | NOLC1 TCF7L2 LEO1 MARK3 SPTA1 WDR70 YTHDC2 ZC3H18 RYK RTF1 GTF2F1 GTF3C1 UHRF1 SGO2 TOPORS NIPBL PML DNMT3A | 6.61e-05 | 1316 | 99 | 18 | int:PARP1 |
| Interaction | SNRNP40 interactions | ACACB TCOF1 RBBP6 CDK12 ZC3H18 GTF2F1 PAXBP1 ATAD2B NKTR CDK11B SPEN PML | 6.74e-05 | 637 | 99 | 12 | int:SNRNP40 |
| Interaction | ZNF330 interactions | NOLC1 LEO1 ZC3H18 ZBTB42 RTF1 GTF2F1 GTF3C1 UHRF1 NIPBL DNMT3A | 6.85e-05 | 446 | 99 | 10 | int:ZNF330 |
| Interaction | LEO1 interactions | 6.86e-05 | 278 | 99 | 8 | int:LEO1 | |
| Interaction | CDC5L interactions | NOLC1 SLK CCDC185 RBBP6 HIP1R ZC3H18 THOC2 PAXBP1 NUP155 PLEC CDC25B SPEN NIPBL PML | 7.32e-05 | 855 | 99 | 14 | int:CDC5L |
| Interaction | SUZ12 interactions | NOLC1 LIMA1 BACH1 ZC3H18 THOC2 PAXBP1 GTF3C1 PABPN1 UHRF1 PLEC HTT PML | 7.48e-05 | 644 | 99 | 12 | int:SUZ12 |
| Interaction | CBX3 interactions | TCF7L2 ATRX TCOF1 RBBP6 CDK12 WDR70 SNRK RTF1 GTF3C1 UHRF1 SPEN NIPBL | 7.70e-05 | 646 | 99 | 12 | int:CBX3 |
| Interaction | CACTIN interactions | 7.78e-05 | 144 | 99 | 6 | int:CACTIN | |
| Interaction | YAP1 interactions | LIMA1 SLK TCOF1 RBBP6 CDK12 WDR70 THOC2 RTF1 GTF3C1 SYTL4 UHRF1 BOD1L1 PLEC SPEN PALLD PML | 8.26e-05 | 1095 | 99 | 16 | int:YAP1 |
| Interaction | EZR interactions | NOLC1 LIMA1 MARK3 SPTA1 DUSP6 APC ADRA1B PROSER2 UQCRFS1 PALLD PML | 8.56e-05 | 553 | 99 | 11 | int:EZR |
| Interaction | GSK3A interactions | 9.50e-05 | 464 | 99 | 10 | int:GSK3A | |
| Interaction | DHX8 interactions | 9.66e-05 | 292 | 99 | 8 | int:DHX8 | |
| Interaction | SPTA1 interactions | 1.00e-04 | 94 | 99 | 5 | int:SPTA1 | |
| Interaction | SLIRP-OT1 interactions | 1.05e-04 | 19 | 99 | 3 | int:SLIRP-OT1 | |
| Interaction | SMC5 interactions | NOLC1 ATRX RBBP6 CDK12 KTN1 ZC3H18 THOC2 PAXBP1 ATAD2B SGO2 BOD1L1 CDK11B SPEN NIPBL PML | 1.06e-04 | 1000 | 99 | 15 | int:SMC5 |
| Interaction | FBXW11 interactions | KDM5B APC YTHDC2 ZC3H18 ZKSCAN1 UHRF1 AKAP13 PLEKHH2 CDC25B PALLD | 1.11e-04 | 473 | 99 | 10 | int:FBXW11 |
| Interaction | ASAP1 interactions | 1.22e-04 | 98 | 99 | 5 | int:ASAP1 | |
| Interaction | SAP18 interactions | 1.30e-04 | 305 | 99 | 8 | int:SAP18 | |
| Interaction | SYNGAP1 interactions | 1.36e-04 | 307 | 99 | 8 | int:SYNGAP1 | |
| Interaction | PSME3 interactions | 1.51e-04 | 398 | 99 | 9 | int:PSME3 | |
| Interaction | ANKRD28 interactions | 1.61e-04 | 235 | 99 | 7 | int:ANKRD28 | |
| Interaction | RNF4 interactions | NOLC1 LIMA1 TCF7L2 TCOF1 RBBP6 CDK12 KTN1 ZCCHC17 THOC2 NUP155 ZKSCAN1 IQSEC1 UHRF1 ZNF740 PLEC TOPORS HTT PML | 1.61e-04 | 1412 | 99 | 18 | int:RNF4 |
| Interaction | ZCCHC10 interactions | 1.65e-04 | 236 | 99 | 7 | int:ZCCHC10 | |
| Interaction | PCNA interactions | 1.66e-04 | 497 | 99 | 10 | int:PCNA | |
| Interaction | PML interactions | NOLC1 LIMA1 TCF7L2 ATRX SPTA1 WDR70 TACC2 THOC2 SYNE2 UHRF1 TOPORS PALLD HTT PML | 1.83e-04 | 933 | 99 | 14 | int:PML |
| Interaction | DYNLT1 interactions | 1.88e-04 | 241 | 99 | 7 | int:DYNLT1 | |
| Interaction | CSNK2A3 interactions | 2.10e-04 | 110 | 99 | 5 | int:CSNK2A3 | |
| Interaction | DBN1 interactions | 2.14e-04 | 417 | 99 | 9 | int:DBN1 | |
| Interaction | YTHDC1 interactions | 2.14e-04 | 417 | 99 | 9 | int:YTHDC1 | |
| Interaction | CIT interactions | NOLC1 LIMA1 TCOF1 RBBP6 KTN1 YTHDC2 SPECC1L THOC2 PAXBP1 NUP155 SLCO1C1 PABPN1 SYNE2 UHRF1 BOD1L1 NKTR PLEC NIPBL | 2.24e-04 | 1450 | 99 | 18 | int:CIT |
| Interaction | PRKACA interactions | 2.36e-04 | 519 | 99 | 10 | int:PRKACA | |
| Interaction | PPWD1 interactions | 2.38e-04 | 113 | 99 | 5 | int:PPWD1 | |
| Interaction | DNMT3B interactions | 2.48e-04 | 114 | 99 | 5 | int:DNMT3B | |
| Interaction | SIRT6 interactions | ATRX TCOF1 APC YTHDC2 NUP155 GTF3C1 SGO2 NKTR CDK11B PALLD PML | 2.59e-04 | 628 | 99 | 11 | int:SIRT6 |
| Interaction | TOP3B interactions | LIMA1 CDK12 KTN1 WDR70 HIP1R CEP192 THOC2 ZBTB42 LYST PPP1R26 ZC3H7A ZNF276 PABPN1 TTLL4 AKAP13 PLEC SPEN HTT | 2.65e-04 | 1470 | 99 | 18 | int:TOP3B |
| Interaction | CAPZA2 interactions | 2.68e-04 | 430 | 99 | 9 | int:CAPZA2 | |
| Interaction | NIFK interactions | 2.73e-04 | 431 | 99 | 9 | int:NIFK | |
| Interaction | RASA2 interactions | 2.75e-04 | 26 | 99 | 3 | int:RASA2 | |
| Interaction | NUP50 interactions | 2.78e-04 | 341 | 99 | 8 | int:NUP50 | |
| Interaction | PPARD interactions | 2.80e-04 | 117 | 99 | 5 | int:PPARD | |
| Interaction | PRC1 interactions | NOLC1 KDM5B LIMA1 ATRX RBBP6 KTN1 APC TACC2 ZC3H18 SPECC1L PABPN1 UHRF1 PLEC SPEN | 2.82e-04 | 973 | 99 | 14 | int:PRC1 |
| Interaction | SIRT7 interactions | NOLC1 TCOF1 YTHDC2 ZC3H18 THOC2 NUP155 GTF3C1 ATAD2B SYNE2 PLEC SPEN NIPBL | 2.86e-04 | 744 | 99 | 12 | int:SIRT7 |
| Interaction | SNRNP27 interactions | 2.96e-04 | 184 | 99 | 6 | int:SNRNP27 | |
| Interaction | PTGES3 interactions | 3.02e-04 | 437 | 99 | 9 | int:PTGES3 | |
| Interaction | ZMAT2 interactions | 3.03e-04 | 119 | 99 | 5 | int:ZMAT2 | |
| Interaction | SULF2 interactions | 3.03e-04 | 119 | 99 | 5 | int:SULF2 | |
| Interaction | FMR1 interactions | TCOF1 RBBP6 APC TACC2 ZBTB42 ZC3H7A ZKSCAN1 IQSEC1 NIPBL AGAP2 | 3.05e-04 | 536 | 99 | 10 | int:FMR1 |
| Interaction | MILR1 interactions | 3.13e-04 | 66 | 99 | 4 | int:MILR1 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 5.12e-05 | 181 | 66 | 6 | 694 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Paf1/RNA polymerase II complex | 1.95e-04 | 6 | 66 | 2 | 1029 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | KDM5B SLK URI1 TCF7L2 ATRX MARK3 APC SPECC1L THOC2 RYK ADGRG6 ATAD2B SYNE2 AKAP13 AKAP11 SPEN NIPBL | 2.10e-08 | 856 | 99 | 17 | M4500 |
| Coexpression | GABRIELY_MIR21_TARGETS | 1.55e-06 | 289 | 99 | 9 | M2196 | |
| Coexpression | BLALOCK_ALZHEIMERS_DISEASE_INCIPIENT_UP | 2.23e-06 | 389 | 99 | 10 | M6520 | |
| Coexpression | MURARO_PANCREAS_BETA_CELL | PRUNE2 SLK RPH3AL ATRX KTN1 APC SPECC1L RAB11FIP1 MTERF4 LYST GTF3C1 SYNE2 IQSEC1 AKAP11 ANKRD12 | 2.61e-06 | 946 | 99 | 15 | M39169 |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 3.29e-06 | 166 | 99 | 7 | M8129 | |
| Coexpression | GSE21063_CTRL_VS_ANTI_IGM_STIM_BCELL_NFATC1_KO_8H_UP | 8.55e-06 | 192 | 99 | 7 | M8272 | |
| Coexpression | GSE21927_SPLEEN_VS_C26GM_TUMOR_MONOCYTE_BALBC_DN | 9.15e-06 | 194 | 99 | 7 | M7573 | |
| Coexpression | GSE21670_UNTREATED_VS_TGFB_IL6_TREATED_CD4_TCELL_UP | 9.15e-06 | 194 | 99 | 7 | M7467 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 9.82e-06 | 363 | 99 | 9 | M41103 | |
| Coexpression | GSE39556_CD8A_DC_VS_NK_CELL_MOUSE_3H_POST_POLYIC_INJ_DN | 1.08e-05 | 199 | 99 | 7 | M9418 | |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SLK URI1 ATRX RBBP6 MARK3 KTN1 DUSP6 SNRK YTHDC2 MDM4 LYST ZNF276 AKAP13 AKAP11 BOD1L1 SPEN NIPBL BRWD1 | 1.09e-05 | 1492 | 99 | 18 | M40023 |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 TCOF1 MIS18A CENPU CEP192 ADGRG6 TTLL4 UHRF1 SGO2 CDC25B PALLD | 1.19e-05 | 578 | 99 | 11 | M2368 |
| Coexpression | BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP | KDM5B SLK TCF7L2 MARK3 BACH1 RAB11FIP1 LYST ZC3H7A ANKRD12 TOPORS NIPBL PALLD BRWD1 | 1.33e-05 | 822 | 99 | 13 | M6782 |
| Coexpression | YOSHIMURA_MAPK8_TARGETS_DN | 1.38e-05 | 379 | 99 | 9 | M1885 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_UP | NOLC1 TCOF1 MIS18A CENPU CEP192 ADGRG6 TTLL4 UHRF1 SGO2 CDC25B PALLD | 1.61e-05 | 597 | 99 | 11 | MM1309 |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | LEO1 ATRX RBBP6 MIS18A CENPU APC THOC2 SGO2 BOD1L1 PLEC NIPBL BRWD1 | 1.78e-05 | 721 | 99 | 12 | M10237 |
| Coexpression | MENON_FETAL_KIDNEY_0_CAP_MESENCHYME_CELLS | 2.37e-05 | 90 | 99 | 5 | M39250 | |
| Coexpression | HAMAI_APOPTOSIS_VIA_TRAIL_UP | LIMA1 SLK KTN1 CENPU APC CEP192 SYNE2 AKAP11 NKTR NIPBL PALLD | 3.81e-05 | 656 | 99 | 11 | M18979 |
| Coexpression | DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER | 3.93e-05 | 100 | 99 | 5 | M14670 | |
| Coexpression | GSE6269_HEALTHY_VS_STAPH_AUREUS_INF_PBMC_UP | 4.79e-05 | 171 | 99 | 6 | M5655 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUMIST_AGE_18_50YO_7DY_UP | URI1 ATRX RBBP6 CDK12 KTN1 DUSP6 WDR70 CENPU APC THOC2 CMAS ATAD2B SYNE2 IQSEC1 NIPBL | 5.00e-05 | 1215 | 99 | 15 | M41122 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | 6.91e-05 | 466 | 99 | 9 | M13522 | |
| Coexpression | GSE18893_TCONV_VS_TREG_2H_TNF_STIM_DN | 9.63e-05 | 194 | 99 | 6 | M7306 | |
| Coexpression | PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP | 9.91e-05 | 195 | 99 | 6 | M13736 | |
| Coexpression | GSE3982_MAC_VS_NEUTROPHIL_DN | 9.91e-05 | 195 | 99 | 6 | M5492 | |
| Coexpression | TBK1.DF_DN | 1.08e-04 | 286 | 99 | 7 | M2864 | |
| Coexpression | GSE2585_CTEC_VS_THYMIC_MACROPHAGE_DN | 1.11e-04 | 199 | 99 | 6 | M6264 | |
| Coexpression | GSE37534_UNTREATED_VS_GW1929_TREATED_CD4_TCELL_PPARG1_AND_FOXP3_TRASDUCED_DN | 1.11e-04 | 199 | 99 | 6 | M8979 | |
| Coexpression | GSE17721_POLYIC_VS_PAM3CSK4_24H_BMDC_UP | 1.11e-04 | 199 | 99 | 6 | M3846 | |
| Coexpression | GSE22103_LPS_VS_GMCSF_AND_IFNG_STIM_NEUTROPHIL_DN | 1.14e-04 | 200 | 99 | 6 | M7791 | |
| Coexpression | GSE23502_WT_VS_HDC_KO_MYELOID_DERIVED_SUPPRESSOR_CELL_BM_UP | 1.14e-04 | 200 | 99 | 6 | M8090 | |
| Coexpression | GSE24634_NAIVE_CD4_TCELL_VS_DAY7_IL4_CONV_TREG_UP | 1.14e-04 | 200 | 99 | 6 | M4590 | |
| Coexpression | GSE27786_LIN_NEG_VS_BCELL_DN | 1.14e-04 | 200 | 99 | 6 | M4768 | |
| Coexpression | BROWNE_HCMV_INFECTION_14HR_DN | 1.18e-04 | 290 | 99 | 7 | M13251 | |
| Coexpression | OSMAN_BLADDER_CANCER_UP | 1.45e-04 | 402 | 99 | 8 | M5275 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_DN | 1.52e-04 | 211 | 99 | 6 | M1866 | |
| Coexpression | WANG_TUMOR_INVASIVENESS_DN | 1.77e-04 | 217 | 99 | 6 | MM778 | |
| Coexpression | NAKAYA_PLASMACYTOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 1.86e-04 | 219 | 99 | 6 | M41199 | |
| Coexpression | IBRAHIM_NRF1_UP | 1.95e-04 | 420 | 99 | 8 | M42509 | |
| Coexpression | PATIL_LIVER_CANCER | KDM5B TCOF1 MIS18A CENPU ZCCHC17 CEP192 RAB11FIP1 NUP155 ZKSCAN1 CDC25B | 1.99e-04 | 660 | 99 | 10 | M1195 |
| Coexpression | PECE_MAMMARY_STEM_CELL_DN | 2.21e-04 | 144 | 99 | 5 | M2535 | |
| Coexpression | SHEN_SMARCA2_TARGETS_UP | 2.25e-04 | 429 | 99 | 8 | M29 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | 2.36e-04 | 432 | 99 | 8 | M41149 | |
| Coexpression | HEVNER_CORTEX_RADIAL_GLIA_PROGENITORS | 2.36e-04 | 432 | 99 | 8 | MM419 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ARHGAP42 KDM5B TCF7L2 RBBP6 HIP1R CEP192 THOC2 ZKSCAN1 TBC1D22A ANKRD12 PLEC HTT DNMT3A | 2.59e-04 | 1102 | 99 | 13 | M2369 |
| Coexpression | STONER_ESOPHAGEAL_CARCINOGENESIS_DN | 2.93e-04 | 7 | 99 | 2 | M1444 | |
| Coexpression | FISCHER_DREAM_TARGETS | NOLC1 TCOF1 RBBP6 MIS18A CENPU CEP192 NUP155 TTLL4 UHRF1 SGO2 CDC25B NIPBL | 2.93e-04 | 969 | 99 | 12 | M149 |
| Coexpression | GSE4984_UNTREATED_VS_VEHICLE_CTRL_TREATED_DC_UP | 3.10e-04 | 155 | 99 | 5 | M6500 | |
| Coexpression | GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN | ARHGAP42 KDM5B TCF7L2 RBBP6 HIP1R CEP192 THOC2 ZKSCAN1 TBC1D22A ANKRD12 PLEC HTT DNMT3A | 3.13e-04 | 1124 | 99 | 13 | MM1070 |
| Coexpression | KOINUMA_TARGETS_OF_SMAD2_OR_SMAD3 | LIMA1 LEO1 MARK3 DUSP6 BACH1 HIP1R SYNE2 UHRF1 AKAP13 PLEC PML | 3.43e-04 | 843 | 99 | 11 | M2356 |
| Coexpression | NUYTTEN_NIPP1_TARGETS_DN | ARHGAP42 TCF7L2 MIS18A KTN1 ITPKA ADGRG6 SYNE2 IQSEC1 UHRF1 HTT BRWD1 | 3.50e-04 | 845 | 99 | 11 | M18090 |
| Coexpression | RICKMAN_METASTASIS_UP | 3.71e-04 | 350 | 99 | 7 | M9752 | |
| Coexpression | MITSIADES_RESPONSE_TO_APLIDIN_DN | 3.79e-04 | 250 | 99 | 6 | M11318 | |
| Coexpression | GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_DN | 4.02e-04 | 164 | 99 | 5 | M8989 | |
| Coexpression | TABULA_MURIS_SENIS_AORTA_FIBROBLAST_OF_CARDIAC_TISSUE_AGEING | URI1 TCF7L2 TBC1D30 MIS18A ZC3H18 MDM4 LYST AKAP13 PLEC NIPBL | 4.10e-04 | 723 | 99 | 10 | MM3672 |
| Coexpression | MATZUK_MEIOTIC_AND_DNA_REPAIR | 4.33e-04 | 39 | 99 | 3 | M1819 | |
| Coexpression | ENK_UV_RESPONSE_KERATINOCYTE_DN | 4.83e-04 | 481 | 99 | 8 | M3898 | |
| Coexpression | CROONQUIST_NRAS_VS_STROMAL_STIMULATION_UP | 5.02e-04 | 41 | 99 | 3 | M8273 | |
| Coexpression | HOEBEKE_LYMPHOID_STEM_CELL_UP | 5.07e-04 | 97 | 99 | 4 | M14698 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_PPARG2_FOXP3_TRANSDUCED_CD4_TCELL_UP | 5.83e-04 | 178 | 99 | 5 | M8996 | |
| Coexpression | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY | 6.23e-04 | 10 | 99 | 2 | MM1261 | |
| Coexpression | MIKKELSEN_PARTIALLY_REPROGRAMMED_TO_PLURIPOTENCY | 6.23e-04 | 10 | 99 | 2 | M1928 | |
| Coexpression | GSE35825_UNTREATED_VS_IFNG_STIM_MACROPHAGE_DN | 6.29e-04 | 181 | 99 | 5 | M8662 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_POORLY_DIFFERENTIATED_UP | 7.49e-04 | 644 | 99 | 9 | M10501 | |
| Coexpression | PGF_UP.V1_UP | 7.83e-04 | 190 | 99 | 5 | M2674 | |
| Coexpression | MARTORIATI_MDM4_TARGETS_FETAL_LIVER_DN | 7.93e-04 | 519 | 99 | 8 | M3395 | |
| Coexpression | BASAKI_YBX1_TARGETS_DN | 7.93e-04 | 398 | 99 | 7 | M14877 | |
| Coexpression | NAKAYA_MYELOID_DENDRITIC_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_UP | 8.05e-04 | 399 | 99 | 7 | M41172 | |
| Coexpression | LEE_EARLY_T_LYMPHOCYTE_UP | 8.42e-04 | 111 | 99 | 4 | M7357 | |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | 8.59e-04 | 194 | 99 | 5 | M7313 | |
| Coexpression | NAKAYA_B_CELL_FLUARIX_FLUVIRIN_AGE_18_50YO_7DY_DN | 8.86e-04 | 294 | 99 | 6 | M41112 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 9.02e-04 | 295 | 99 | 6 | M39121 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_CYCLING_DC_CELL | LEO1 TCOF1 MIS18A CENPU ZCCHC17 ZC3H18 CEP192 PAXBP1 NUP155 PCIF1 UHRF1 SGO2 TMEM102 CDC25B | 9.09e-04 | 1423 | 99 | 14 | M45722 |
| Coexpression | FIGUEROA_AML_METHYLATION_CLUSTER_5_UP | 9.09e-04 | 12 | 99 | 2 | M2172 | |
| Coexpression | GSE17974_1H_VS_72H_UNTREATED_IN_VITRO_CD4_TCELL_UP | 9.21e-04 | 197 | 99 | 5 | M4237 | |
| Coexpression | GSE20500_CTRL_VS_RETINOIC_ACID_TREATED_CD4_TCELL_DN | 9.42e-04 | 198 | 99 | 5 | M7701 | |
| Coexpression | GSE1432_CTRL_VS_IFNG_1H_MICROGLIA_DN | 9.42e-04 | 198 | 99 | 5 | M3401 | |
| Coexpression | GSE36826_NORMAL_VS_STAPH_AUREUS_INF_SKIN_UP | 9.42e-04 | 198 | 99 | 5 | M9534 | |
| Coexpression | GSE6259_BCELL_VS_CD8_TCELL_DN | 9.42e-04 | 198 | 99 | 5 | M6736 | |
| Coexpression | GSE2770_IL12_AND_TGFB_VS_IL4_TREATED_ACT_CD4_TCELL_2H_DN | 9.42e-04 | 198 | 99 | 5 | M6128 | |
| Coexpression | GSE22886_NAIVE_TCELL_VS_NKCELL_DN | 9.42e-04 | 198 | 99 | 5 | M4415 | |
| Coexpression | GSE22886_IGM_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 9.42e-04 | 198 | 99 | 5 | M4451 | |
| Coexpression | GSE37533_PPARG1_FOXP3_VS_FOXP3_TRANSDUCED_CD4_TCELL_PIOGLITAZONE_TREATED_DN | 9.63e-04 | 199 | 99 | 5 | M8974 | |
| Coexpression | GSE24142_DN2_VS_DN3_THYMOCYTE_ADULT_DN | 9.63e-04 | 199 | 99 | 5 | M4567 | |
| Coexpression | GSE5589_IL6_KO_VS_IL10_KO_LPS_AND_IL10_STIM_MACROPHAGE_45MIN_DN | 9.63e-04 | 199 | 99 | 5 | M6660 | |
| Coexpression | GSE17721_CTRL_VS_PAM3CSK4_1H_BMDC_DN | 9.63e-04 | 199 | 99 | 5 | M3731 | |
| Coexpression | GSE3982_MAST_CELL_VS_CENT_MEMORY_CD4_TCELL_UP | 9.63e-04 | 199 | 99 | 5 | M5446 | |
| Coexpression | GSE17974_0H_VS_2H_IN_VITRO_ACT_CD4_TCELL_DN | 9.63e-04 | 199 | 99 | 5 | M4159 | |
| Coexpression | GSE21670_IL6_VS_TGFB_AND_IL6_TREATED_STAT3_KO_CD4_TCELL_DN | 9.63e-04 | 199 | 99 | 5 | M7451 | |
| Coexpression | GSE21774_CD62L_POS_CD56_DIM_VS_CD62L_NEG_CD56_DIM_NK_CELL_UP | 9.63e-04 | 199 | 99 | 5 | M7491 | |
| Coexpression | GSE21379_WT_VS_SAP_KO_TFH_CD4_TCELL_DN | 9.63e-04 | 199 | 99 | 5 | M7498 | |
| Coexpression | GSE31082_DP_VS_CD8_SP_THYMOCYTE_UP | 9.85e-04 | 200 | 99 | 5 | M5066 | |
| Coexpression | GSE14308_TH1_VS_INDUCED_TREG_UP | 9.85e-04 | 200 | 99 | 5 | M3378 | |
| Coexpression | GSE14308_INDUCED_VS_NATURAL_TREG_DN | 9.85e-04 | 200 | 99 | 5 | M3399 | |
| Coexpression | GSE22527_ANTI_CD3_INVIVO_VS_UNTREATED_MOUSE_TREG_DN | 9.85e-04 | 200 | 99 | 5 | M7709 | |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_UP | 9.85e-04 | 200 | 99 | 5 | M8050 | |
| Coexpression | GSE1925_CTRL_VS_24H_IFNG_STIM_IFNG_PRIMED_MACROPHAGE_DN | 9.85e-04 | 200 | 99 | 5 | M6299 | |
| Coexpression | GSE13411_SWITCHED_MEMORY_BCELL_VS_PLASMA_CELL_UP | 9.85e-04 | 200 | 99 | 5 | M3251 | |
| Coexpression | GSE36392_EOSINOPHIL_VS_MAC_IL25_TREATED_LUNG_UP | 9.85e-04 | 200 | 99 | 5 | M5280 | |
| Coexpression | GSE28726_ACT_CD4_TCELL_VS_ACT_VA24NEG_NKTCELL_DN | 9.85e-04 | 200 | 99 | 5 | M8306 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | NOLC1 URI1 LEO1 ATRX TCOF1 RBBP6 MARK3 MIS18A KTN1 CENPU APC ZCCHC17 CEP192 THOC2 ATAD2B SYNE2 SGO2 BOD1L1 CDK11B TOPORS NIPBL BRWD1 | 5.79e-08 | 1257 | 99 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#3_top-relative-expression-ranked_1000 | 6.37e-07 | 275 | 99 | 10 | gudmap_developingGonad_e14.5_ epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | LIMA1 SLK URI1 RPH3AL ACACB ATRX TCOF1 KTN1 APC ZNF276 PAXBP1 ATAD2B SYNE2 VAX2 BOD1L1 CDK11B NIPBL BRWD1 | 6.45e-07 | 989 | 99 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | NOLC1 URI1 LEO1 ATRX TCOF1 RBBP6 MARK3 MIS18A KTN1 CENPU APC ZCCHC17 CEP192 THOC2 ATAD2B SYNE2 SGO2 BOD1L1 CDK11B TOPORS NIPBL BRWD1 | 7.53e-07 | 1459 | 99 | 22 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.30e-06 | 230 | 99 | 9 | gudmap_developingGonad_e16.5_ovary_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.46e-06 | 259 | 99 | 9 | gudmap_developingGonad_e12.5_epididymis_k3_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | LIMA1 SLK URI1 ATRX APC ZNF276 ATAD2B BOD1L1 CDK11B NIPBL BRWD1 | 5.50e-06 | 432 | 99 | 11 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | ZCCHC17 CEP192 THOC2 MTERF4 ADGRG6 ZC3H7A ZNF276 ATAD2B SGO2 AKAP13 BOD1L1 ANKRD12 CDK11B TNS3 DNMT3A | 7.16e-06 | 834 | 99 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | ARHGAP42 NOLC1 LIMA1 LEO1 ATRX APC ZCCHC17 CEP192 THOC2 ATAD2B SGO2 BOD1L1 CDK11B UQCRFS1 TOPORS NIPBL DNMT3A BRWD1 | 1.54e-05 | 1241 | 99 | 18 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_500_k-means-cluster#5 | 2.67e-05 | 186 | 99 | 7 | Facebase_RNAseq_e10.5_Mandibular Arch_500_K5 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.89e-05 | 127 | 99 | 6 | gudmap_developingGonad_e16.5_epididymis_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#5 | SLK URI1 ATRX KTN1 APC ADGRG6 GTF3C1 ATAD2B SYNE2 BOD1L1 CDK11B NIPBL | 3.62e-05 | 629 | 99 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_2500_K5 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | LIMA1 ATRX MTERF4 ADGRG6 ZC3H7A ZNF276 ATAD2B SGO2 AKAP13 ANKRD12 PLEKHH2 NIPBL TNS3 | 4.17e-05 | 744 | 99 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_2500_K4 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | ARHGAP42 NOLC1 LIMA1 LEO1 ATRX DUSP6 APC ZCCHC17 CEP192 THOC2 ATAD2B SGO2 BOD1L1 CDK11B UQCRFS1 TOPORS NIPBL DNMT3A BRWD1 | 4.19e-05 | 1468 | 99 | 19 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.15e-05 | 281 | 99 | 8 | gudmap_developingGonad_e18.5_epididymis_1000_k3 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#2_top-relative-expression-ranked_1000 | 5.77e-05 | 210 | 99 | 7 | gudmap_developingGonad_e18.5_ovary_1000_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | ARHGAP42 LIMA1 URI1 ATRX TCOF1 CENPU APC CEP192 THOC2 ZC3H7A ATAD2B SYNE2 SGO2 BOD1L1 ANKRD12 CDK11B NIPBL | 6.27e-05 | 1252 | 99 | 17 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.31e-05 | 146 | 99 | 6 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#2 | SLK URI1 ATRX MARK3 APC ZCCHC17 THOC2 RTF1 GTF3C1 ATAD2B BRWD1 | 6.42e-05 | 564 | 99 | 11 | Facebase_RNAseq_e9.5_Mandibular Arch_2500_K2 |
| CoexpressionAtlas | DevelopingGonad_P2_ovary_emap-30224_k-means-cluster#5_top-relative-expression-ranked_1000 | 7.61e-05 | 151 | 99 | 6 | gudmap_developingGonad_P2_ovary_1000_k5 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 7.77e-05 | 298 | 99 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_ovary_emap-9563_top-relative-expression-ranked_1000 | ATRX SPTA1 BACH1 YTHDC2 THOC2 GTF2F1 SYTL4 SYNE2 NKTR ANKRD12 PLEC HTT DNMT3A | 8.17e-05 | 795 | 99 | 13 | gudmap_developingGonad_e16.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | LIMA1 RPH3AL ACACB ATRX ZC3H7A ZNF276 SYNE2 CDK11B TOPORS NIPBL | 1.00e-04 | 492 | 99 | 10 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 1.04e-04 | 311 | 99 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.67e-04 | 249 | 99 | 7 | gudmap_developingGonad_P2_epididymis_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000 | LIMA1 TCF7L2 RPH3AL ACACB ATRX ZC3H7A ZNF276 ATAD2B SYNE2 AKAP11 CDK11B TOPORS NIPBL PML | 1.87e-04 | 985 | 99 | 14 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | NOLC1 TCF7L2 ATRX TCOF1 RBBP6 KTN1 ATAD2B SYNE2 UHRF1 BOD1L1 CDK11B CDC25B NIPBL BRWD1 | 1.95e-04 | 989 | 99 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_k-means-cluster#3_top-relative-expression-ranked_200 | 2.36e-04 | 26 | 99 | 3 | gudmap_developingGonad_e18.5_ovary_200_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 2.82e-04 | 192 | 99 | 6 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.40e-04 | 71 | 99 | 4 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k2_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | TCF7L2 ATRX BACH1 THOC2 PABPN1 SYNE2 NKTR ANKRD12 PLEC TOPORS HTT DNMT3A | 3.49e-04 | 801 | 99 | 12 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_500 | 3.60e-04 | 201 | 99 | 6 | gudmap_developingKidney_e15.5_500_k3 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_anlage of loop of Henle_emap-31283_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.99e-04 | 379 | 99 | 8 | gudmap_developingKidney_e15.5_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000 | LIMA1 RPH3AL ACACB ATRX KTN1 DUSP6 ZC3H7A ATAD2B SGO2 VAX2 CDK11B NIPBL PGBD5 | 6.16e-04 | 979 | 99 | 13 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | 8.54e-04 | 532 | 99 | 9 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 | |
| ToppCell | (01)_IL1RL1+-(2)_GFP_FOXI1|(01)_IL1RL1+ / shred by cell type by condition | LIMA1 ATRX RBBP6 KTN1 DUSP6 THOC2 RTF1 SYNE2 BOD1L1 ANKRD12 NIPBL PALLD | 2.65e-14 | 199 | 99 | 12 | a2f7d0cabf35b80fe239fae34a77bf9344d5d743 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | ATRX MDM4 PAXBP1 ATAD2B SYNE2 AKAP13 BOD1L1 NKTR ANKRD12 NIPBL | 2.66e-11 | 200 | 99 | 10 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 6.63e-10 | 199 | 99 | 9 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 6.63e-10 | 199 | 99 | 9 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 6.63e-10 | 199 | 99 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 9.11e-09 | 186 | 99 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | H1299-infected-SARSCoV2|infected / Cell line, Condition and Strain | 1.43e-08 | 197 | 99 | 8 | 0fa3e4cf93e77d78b1f97b906c5b13ca741ae17e | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 1.54e-08 | 199 | 99 | 8 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | mild-HLA-DR+_CD83+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.60e-08 | 200 | 99 | 8 | 934c2efc780318c66d667ca75be0de350361d351 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 2.58e-08 | 138 | 99 | 7 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-promonocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-07 | 182 | 99 | 7 | bc8d621be57f76d718d9b0f11e023b0f4dcb668d | |
| ToppCell | droplet-Tongue-nan|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-07 | 188 | 99 | 7 | d62cc37e86b7b186e53aeb7f421c4e5ee28f23bd | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference|renal_cortex_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.22e-07 | 189 | 99 | 7 | a48df46274d51e84ffb40264646de7346104efb9 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-07 | 194 | 99 | 7 | e3d63874111d1e8da3977329426e4dcf68d6de87 | |
| ToppCell | CV-Moderate-6|Moderate / Virus stimulation, Condition and Cluster | 2.74e-07 | 195 | 99 | 7 | 2b8a72d7e755b9655c7a496000d10ff06e50862b | |
| ToppCell | CV-Moderate-6|CV / Virus stimulation, Condition and Cluster | 2.84e-07 | 196 | 99 | 7 | 7bced0cc2112697593c478fa291b8ed3941fb811 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 3.04e-07 | 198 | 99 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-07 | 199 | 99 | 7 | fd1d1b95e01719e3d0a17d9d1f29717a47209d32 | |
| ToppCell | (04)_Interm._basal>secr.-(2)_GFP_FOXI1|(04)_Interm._basal>secr. / shred by cell type by condition | 3.14e-07 | 199 | 99 | 7 | 53ca3861f9e00dab3f3fbefb0837857ee39ab084 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW13-Stem_cells-Stem_cells|GW13 / Sample Type, Dataset, Time_group, and Cell type. | 3.14e-07 | 199 | 99 | 7 | 91882af9dc7265c9b419f4415cbcf656087a2ab3 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.25e-07 | 200 | 99 | 7 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Mild/Remission-B_naive-8|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.47e-06 | 173 | 99 | 6 | 694d02c4d2dc2de4b344544f9124fec40fcf7d8f | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-06 | 185 | 99 | 6 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.87e-06 | 187 | 99 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 192 | 99 | 6 | 2de242d81dc085ae734eb7d1f091af9a542e0866 | |
| ToppCell | H1299-infected|H1299 / Cell line, Condition and Strain | 4.50e-06 | 192 | 99 | 6 | 9cf8049bdc3e0f81ce69042beac72b08d8f38b4e | |
| ToppCell | facs-Marrow-T-cells-3m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 192 | 99 | 6 | ba2a683472a8b785dbf666dc6e94356d879486c3 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-06 | 192 | 99 | 6 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.64e-06 | 193 | 99 | 6 | 08696a99309f5b088692ddac8cca35413b5e810d | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c02-MS4A1-CD27|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.78e-06 | 194 | 99 | 6 | d852aebf7a763b9a776c4570711f0c759f591910 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.92e-06 | 195 | 99 | 6 | 481989d2e5bd2582da3d86b0155c4d6615317067 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.92e-06 | 195 | 99 | 6 | 6108a27523d1b93a7fbe35cb95704a5ad9071e3c | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.92e-06 | 195 | 99 | 6 | b57132802cb977551e214880984f3edcd375474f | |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|Classical_Monocyte / Disease condition and Cell class | 5.22e-06 | 197 | 99 | 6 | e666f6580e9a20b5e550f02125706db17eec8510 | |
| ToppCell | systemic_lupus_erythematosus-flare|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.37e-06 | 198 | 99 | 6 | 4c93ee921d56132d80832d8e94563f32ccf13bbc | |
| ToppCell | 3'-Adult-Distal_Rectal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-06 | 198 | 99 | 6 | 7ad7726fc405806b1d7824f58548073ea5e0c70b | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell-TA|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-06 | 198 | 99 | 6 | 1fbec311f2c987ca90a023a5989128c05aa12d5c | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-06 | 198 | 99 | 6 | ceede961ad9af6a3159db7efaa5087bf38aafc2d | |
| ToppCell | 3'-Adult-Distal_Rectal-Epithelial-epithelial_progenitor_cell|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.37e-06 | 198 | 99 | 6 | 4f26a60e99f42343e5af7221723e108a1a1b7827 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.53e-06 | 199 | 99 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 5.53e-06 | 199 | 99 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type. | 5.53e-06 | 199 | 99 | 6 | b2d7dea11207cca63d688f8051143850b29dbdf0 | |
| ToppCell | (05)_Secretory-(2)_GFP_FOXI1|(05)_Secretory / shred by cell type by condition | 5.53e-06 | 199 | 99 | 6 | d72d87e1e530ed894c0ad5e7b5b2b1d6b59fa098 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related-OPC|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 200 | 99 | 6 | 02594c1edbc9f2cf831639cd83363abd2551cb94 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW26-OPC_related|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 5.69e-06 | 200 | 99 | 6 | 46521d83b917b0357601db8783c8da6b73730d60 | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 5.69e-06 | 200 | 99 | 6 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | 10x5'-Liver-Myeloid_Mac-Intestinal_macrophages|Liver / Manually curated celltypes from each tissue | 2.58e-05 | 156 | 99 | 5 | 9a897fc79c4fae94c5f2e9012d65297f9225e5e3 | |
| ToppCell | 356C-Myeloid-Monocyte-CD16+_Monocyte|356C / Donor, Lineage, Cell class and subclass (all cells) | 3.38e-05 | 165 | 99 | 5 | 35a6de30438de364ccca948fc932da541a69ef89 | |
| ToppCell | lymphoid-B_cell-pro-B|B_cell / Lineage, cell class and subclass | 4.12e-05 | 172 | 99 | 5 | da1e2e54f442f5c2032c857c4812e9060f2053cd | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 99 | 5 | e1378201b15ffb98e196ac39fe3ee4b4078953bd | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-B_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.24e-05 | 173 | 99 | 5 | d56e337eae727a29cd53cfd628e1b3c0a98e1f51 | |
| ToppCell | facs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.24e-05 | 173 | 99 | 5 | 99532bb768ee35fed939a377acb5215d3f8904bd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.85e-05 | 178 | 99 | 5 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | MatrixFB-Fibroblast-A|MatrixFB / shred on cell class and cell subclass (v4) | 5.12e-05 | 180 | 99 | 5 | adc64ad6033af705dd7b9163a83e20ef5c59f6eb | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-5|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 5.25e-05 | 181 | 99 | 5 | 8fcc9e77fee7c248df26b6c59b10e672242e2084 | |
| ToppCell | 3'_v3-bone_marrow-Hematopoietic_progenitors-Progenitor_Myeloid|bone_marrow / Manually curated celltypes from each tissue | 5.39e-05 | 182 | 99 | 5 | 6745d464c3ff289726aa8164e9a43f407f8e4380 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 182 | 99 | 5 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.39e-05 | 182 | 99 | 5 | be48ce85991bceeff938ba080e6bf9cc62176b05 | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 5.68e-05 | 184 | 99 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | droplet-Lung-LUNG-30m-Myeloid-Proliferating_Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-05 | 184 | 99 | 5 | 16aa8e88bdd51b1d132d5cf33c29963b384a8bae | |
| ToppCell | systemic_lupus_erythematosus-managed-Hematopoietic-progenitor_cell-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 5.82e-05 | 185 | 99 | 5 | 2c07991e0907ded67e21ab2e66be21695842ed01 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 185 | 99 | 5 | afbb88325e4a81c15ac1d0a004e3e1f4ba2ee87b | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.82e-05 | 185 | 99 | 5 | 775b72319ef6acffd2c9a74293b9c1bccea33f42 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-alveolar_macrophage-proliferating_alveolar_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.82e-05 | 185 | 99 | 5 | b4af9ae4c358b48357cb135b740266e1652d886a | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | f1aa0c58336d23bcbe52a59e7af954d20085bdb6 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 8f77e552e613b6e124443c7f6ef5c1316a5ff8db | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.98e-05 | 186 | 99 | 5 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-alveolar_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 187 | 99 | 5 | f0c6e53035b00772377c4d5f761b4d11026b911a | |
| ToppCell | PND03|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.13e-05 | 187 | 99 | 5 | b3fcb36d853adfdea7172c5591de06f027e50af3 | |
| ToppCell | droplet-Lung-nan-18m-Myeloid-Alveolar_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.13e-05 | 187 | 99 | 5 | f20e7a1751694390f535ffb27b97e887220f8695 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 6.29e-05 | 188 | 99 | 5 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.29e-05 | 188 | 99 | 5 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Neuronal-neuron_precursor-cycling_neuroblast|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.44e-05 | 189 | 99 | 5 | 815afad947ed77a8b03724bf78014799fed34f54 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.44e-05 | 189 | 99 | 5 | b13f315f617840eb5143a4e8a33a657c20365c21 | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.44e-05 | 189 | 99 | 5 | b2542b6fcf7bc10d29158d42b03182a939ff135a | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC|World / Primary Cells by Cluster | 6.44e-05 | 189 | 99 | 5 | ddf5be73912570c32c50f4ac2902da9b590526f8 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.44e-05 | 189 | 99 | 5 | 904b8337e2cabac2f0bf5dad5598fc429581ed81 | |
| ToppCell | Non-neuronal-Non-dividing-OPC|World / Primary Cells by Cluster | 6.44e-05 | 189 | 99 | 5 | 13848a031ab896b4b24c8319e4745b9b17ff9cfd | |
| ToppCell | Non-neuronal-Non-dividing-OPC-OPC-30|World / Primary Cells by Cluster | 6.44e-05 | 189 | 99 | 5 | 313d165fad541ec6e8dd524b88856e2c93eeb681 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 190 | 99 | 5 | e1c02fe6fa43a36381cb9f02569fa9b1c5f5efdc | |
| ToppCell | (02)_Cycling_Basal_(regeneration)|World / shred by cell type and Timepoint | 6.61e-05 | 190 | 99 | 5 | 53f017a11ca5ebe9025558e12cedc409cab2e5aa | |
| ToppCell | droplet-Lung-1m-Hematologic-myeloid-alveolar_macrophage|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.61e-05 | 190 | 99 | 5 | da58227565ad6a690828dd8554dd3670222f8582 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 6.61e-05 | 190 | 99 | 5 | 6de15ec88426fbf52acb0a8371f82cf03b6a6237 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 191 | 99 | 5 | 60c986d2dcbc19d9338c03da6cb5e1d92fd48f8e | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 6.77e-05 | 191 | 99 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 191 | 99 | 5 | 09db184cb90fe282a14474d7217068c58092c6f8 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.77e-05 | 191 | 99 | 5 | 973117730d6ba5f127e7a0bfabfd0ff2ca7ac131 | |
| ToppCell | Proliferating|World / shred by cell class for mouse tongue | 6.94e-05 | 192 | 99 | 5 | f081f3f957cc782294e118fcc1055f6a4264ee98 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.11e-05 | 193 | 99 | 5 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | droplet-Tongue-nan-24m-Epithelial-proliferating|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.11e-05 | 193 | 99 | 5 | f20b90e3f3f5c9a1ae51c5ebe6d3adb954a142f2 | |
| ToppCell | Mild/Remission-B_naive-8|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 7.47e-05 | 195 | 99 | 5 | 0a3221e4d1fa31a35868bdda0f0cc873c233b407 | |
| ToppCell | Adult-Immune-alveolar_macrophage_(MARCO_positive)|Adult / Lineage, Cell type, age group and donor | 7.47e-05 | 195 | 99 | 5 | 55e25f702af19146a161861cfd15f40bbda1dc35 | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_monocytic-classical_monocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 7.65e-05 | 196 | 99 | 5 | 28e9e191361966df3a9bd48450090577aa72a999 | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-OPC-like-OPC-like-F|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 7.65e-05 | 196 | 99 | 5 | 455a2a1c98da413c8e9617b964b6ed141ed3a3be | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 7.84e-05 | 197 | 99 | 5 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 8.03e-05 | 198 | 99 | 5 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | COVID-19_Convalescent-Classical_Monocyte-cMono_2|COVID-19_Convalescent / Disease condition and Cell class | 8.03e-05 | 198 | 99 | 5 | f65fd9b773aeafa55e38309479954a8e41371f52 | |
| ToppCell | Healthy_Control-Myeloid-Macrophages-FCN1+SPP1+|Healthy_Control / Condition, Lineage, Cell class and cell subclass | 8.03e-05 | 198 | 99 | 5 | aa90326b82e21de37af5642df6a70a8b21af7f04 | |
| ToppCell | Control-B_naive-2|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.03e-05 | 198 | 99 | 5 | b9aab1c2a0aeb5f95d24b321fe460bbab9e4e8a1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.41e-04 | 50 | 66 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_B_CELLS_1 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 2.41e-04 | 50 | 66 | 4 | GAVISH_3CA_MALIGNANT_METAPROGRAM_4_CHROMATIN | |
| Drug | Clorgyline | 5.13e-08 | 168 | 99 | 9 | ctd:D003010 | |
| Drug | irinotecan HCl; Down 200; 100uM; PC3; HT_HG-U133A | 8.23e-07 | 171 | 99 | 8 | 7535_DN | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 9.38e-07 | 174 | 99 | 8 | 7530_DN | |
| Drug | deoxynivalenol | NOLC1 ATRX TCOF1 DUSP6 MDM4 NUP155 UHRF1 PLEC NIPBL PALLD PML DNMT3A | 1.21e-06 | 481 | 99 | 12 | ctd:C007262 |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; PC3; HT_HG-U133A | 1.21e-06 | 180 | 99 | 8 | 4541_DN | |
| Drug | PNU-0251126 [267429-19-6]; Down 200; 10uM; PC3; HT_HG-U133A | 2.04e-06 | 193 | 99 | 8 | 7388_DN | |
| Drug | Perphenazine [58-39-9]; Down 200; 10uM; PC3; HG-U133A | 2.21e-06 | 195 | 99 | 8 | 1956_DN | |
| Drug | colchicine; Down 200; 1uM; SKMEL5; HG-U133A | 2.21e-06 | 195 | 99 | 8 | 630_DN | |
| Drug | Levodopa [59-92-7]; Down 200; 20.2uM; HL60; HG-U133A | 2.57e-06 | 199 | 99 | 8 | 1972_DN | |
| Drug | ICI 182,780; Down 200; 1uM; MCF7; HT_HG-U133A_EA | 1.24e-05 | 177 | 99 | 7 | 985_DN | |
| Drug | Camptothecine (S,+) [7689-03-4]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 1.49e-05 | 182 | 99 | 7 | 3887_DN | |
| Drug | Harmine hydrochloride [343-27-1]; Down 200; 16uM; MCF7; HT_HG-U133A | 1.66e-05 | 185 | 99 | 7 | 7209_DN | |
| Drug | MS-275; Down 200; 10uM; PC3; HT_HG-U133A | 1.90e-05 | 189 | 99 | 7 | 7074_DN | |
| Drug | colcemid; Up 200; 11.7uM; MCF7; HT_HG-U133A_EA | 1.97e-05 | 190 | 99 | 7 | 1103_UP | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 2.03e-05 | 191 | 99 | 7 | 4168_DN | |
| Drug | Meticrane [1084-65-7]; Up 200; 14.6uM; PC3; HT_HG-U133A | 2.10e-05 | 192 | 99 | 7 | 1792_UP | |
| Drug | Hexylcaine hydrochloride [532-76-3]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.25e-05 | 194 | 99 | 7 | 3447_DN | |
| Drug | Omeprazole [73590-58-6]; Down 200; 11.6uM; HL60; HT_HG-U133A | 2.25e-05 | 194 | 99 | 7 | 2467_DN | |
| Drug | Palmatine chloride [3486-67-7]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.32e-05 | 195 | 99 | 7 | 4957_DN | |
| Drug | Rapamycin; Down 200; 0.1uM; PC3; HT_HG-U133A | 2.32e-05 | 195 | 99 | 7 | 1207_DN | |
| Drug | Clorsulon [60200-06-8]; Down 200; 10.6uM; MCF7; HT_HG-U133A | 2.32e-05 | 195 | 99 | 7 | 2884_DN | |
| Drug | Riluzole hydrochloride; Down 200; 14.8uM; MCF7; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 4689_DN | |
| Drug | Ivermectin [70288-86-7]; Down 200; 4.6uM; PC3; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 2051_DN | |
| Drug | Tranylcypromine hydrochloride [1986-47-6]; Up 200; 23.6uM; PC3; HT_HG-U133A | 2.40e-05 | 196 | 99 | 7 | 2101_UP | |
| Drug | Paroxetine maleate [64006-44-6]; Down 200; 1uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 4556_DN | |
| Drug | Mimosine [500-44-7]; Up 200; 20.2uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 6703_UP | |
| Drug | Mephenesin [59-47-2]; Down 200; 22uM; PC3; HT_HG-U133A | 2.48e-05 | 197 | 99 | 7 | 7374_DN | |
| Drug | Dehydrocholic acid [81-23-2]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 5681_DN | |
| Drug | Bromopride [4093-35-0]; Up 200; 11.6uM; HL60; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 2182_UP | |
| Drug | Biotin [58-85-5]; Up 200; 16.4uM; PC3; HT_HG-U133A | 2.56e-05 | 198 | 99 | 7 | 6689_UP | |
| Drug | benz(a)anthracene | TCF7L2 LEO1 TCOF1 RBBP6 RAB11FIP1 MDM4 ZC3H7A ADRA1B PAXBP1 ATAD2B SYNE2 AKAP13 NKTR ANKRD12 PROSER2 PALLD BRWD1 | 2.60e-05 | 1251 | 99 | 17 | ctd:C030935 |
| Drug | Harpagoside [19210-12-9]; Down 200; 8uM; MCF7; HT_HG-U133A | 2.65e-05 | 199 | 99 | 7 | 7355_DN | |
| Drug | Fluvoxamine maleate [61718-82-9]; Down 200; 9.2uM; HL60; HT_HG-U133A | 2.65e-05 | 199 | 99 | 7 | 2913_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Down 200; 10.2uM; PC3; HT_HG-U133A | 2.73e-05 | 200 | 99 | 7 | 2063_DN | |
| Drug | Thimerosal | LIMA1 ACACB ATRX CENPU APC GTF2F1 SYTL4 ATAD2B SYNE2 AKAP11 BOD1L1 SPEN NIPBL PML DNMT3A BRWD1 | 5.75e-05 | 1199 | 99 | 16 | ctd:D013849 |
| Drug | bromazepam | 1.11e-04 | 57 | 99 | 4 | CID000002441 | |
| Drug | 2,4,4'-trichlorobiphenyl | PRUNE2 KDM5B TFEC ACACB SPTA1 MIS18A CENPU SNRK ITPKA NUP155 ATAD2B SYNE2 UHRF1 ANKRD12 CDC25B TNS3 AGAP2 | 1.16e-04 | 1411 | 99 | 17 | ctd:C081766 |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; PC3; HG-U133A | 1.25e-04 | 177 | 99 | 6 | 1951_UP | |
| Drug | Ketoconazole [65277-42-1]; Down 200; 7.6uM; HL60; HT_HG-U133A | 1.41e-04 | 181 | 99 | 6 | 1285_DN | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 1.41e-04 | 181 | 99 | 6 | 1236_UP | |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | PRUNE2 KDM5B TFEC ACACB SPTA1 MIS18A CENPU SNRK ITPKA NUP155 ATAD2B SYNE2 UHRF1 ANKRD12 CDC25B TNS3 AGAP2 | 1.49e-04 | 1441 | 99 | 17 | ctd:C009828 |
| Drug | Betamethasone [378-44-9]; Up 200; 10.2uM; HL60; HG-U133A | 1.50e-04 | 183 | 99 | 6 | 1590_UP | |
| Drug | Terbutaline hemisulfate [23031-32-5]; Up 200; 7.2uM; PC3; HT_HG-U133A | 1.50e-04 | 183 | 99 | 6 | 5764_UP | |
| Drug | irinotecan HCl; Down 200; 100uM; MCF7; HT_HG-U133A | 1.50e-04 | 183 | 99 | 6 | 7498_DN | |
| Drug | GW8510; Down 200; 10uM; MCF7; HT_HG-U133A | 1.50e-04 | 183 | 99 | 6 | 7062_DN | |
| Drug | Prenylamine lactate [69-43-2]; Up 200; 9.6uM; HL60; HG-U133A | 1.54e-04 | 184 | 99 | 6 | 1737_UP | |
| Drug | genistein; Down 200; 10uM; HL60; HT_HG-U133A | 1.74e-04 | 188 | 99 | 6 | 1176_DN | |
| Drug | Primaquine diphosphate [63-45-6]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 1.74e-04 | 188 | 99 | 6 | 4845_DN | |
| Drug | CP-690334-01 [459212-38-5]; Up 200; 10uM; PC3; HT_HG-U133A | 1.74e-04 | 188 | 99 | 6 | 3823_UP | |
| Drug | Coal Tar | 1.77e-04 | 360 | 99 | 8 | ctd:D003033 | |
| Drug | Flupentixol dihydrochloride cis-(Z) [2413-38-9]; Down 200; 7.8uM; HL60; HT_HG-U133A | 1.79e-04 | 189 | 99 | 6 | 1288_DN | |
| Drug | Dexamethasone acetate [1177-87-3]; Up 200; 9.2uM; HL60; HG-U133A | 1.84e-04 | 190 | 99 | 6 | 1396_UP | |
| Drug | Tubocurarine chloride pentahydrate (+) [6989-98-6]; Up 200; 5.2uM; MCF7; HT_HG-U133A | 1.84e-04 | 190 | 99 | 6 | 2887_UP | |
| Drug | Phenformin hydrochloride [834-28-6]; Down 200; 16.6uM; PC3; HT_HG-U133A | 1.89e-04 | 191 | 99 | 6 | 4283_DN | |
| Drug | Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A | 1.89e-04 | 191 | 99 | 6 | 6644_DN | |
| Drug | Meclofenoxate hydrochloride [3685-84-5]; Down 200; 13.6uM; PC3; HT_HG-U133A | 1.95e-04 | 192 | 99 | 6 | 4268_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.95e-04 | 192 | 99 | 6 | 6435_DN | |
| Drug | Phenacetin [62-44-2]; Down 200; 22.4uM; HL60; HT_HG-U133A | 1.95e-04 | 192 | 99 | 6 | 2471_DN | |
| Drug | radicicol; Up 200; 0.1uM; HL60; HG-U133A | 2.00e-04 | 193 | 99 | 6 | 544_UP | |
| Drug | Haloperidol [52-86-8]; Up 200; 10.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 5273_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 4321_DN | |
| Drug | Decamethonium bromide [541-22-0]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 4174_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.00e-04 | 193 | 99 | 6 | 5268_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 2069_UP | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 1239_UP | |
| Drug | Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 4727_DN | |
| Drug | (S)-(-)-Cycloserine [339-72-0]; Down 200; 39.2uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 4524_DN | |
| Drug | Midodrine hydrochloride [3092-17-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 2087_DN | |
| Drug | Pyrantel tartrate [33401-94-4]; Up 200; 11.2uM; HL60; HG-U133A | 2.06e-04 | 194 | 99 | 6 | 1413_UP | |
| Drug | Fluphenazine dihydrochloride [146-56-5]; Down 200; 7.8uM; MCF7; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 3194_DN | |
| Drug | Menadione [58-27-5]; Down 200; 23.2uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 4662_DN | |
| Drug | Diethylstilbestrol [56-53-1]; Up 200; 15uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 3812_UP | |
| Drug | 5194442; Down 200; 20uM; PC3; HT_HG-U133A | 2.06e-04 | 194 | 99 | 6 | 6553_DN | |
| Drug | Felodipine [72509-76-3]; Up 200; 10.4uM; PC3; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 6695_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Down 200; 11uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 5359_DN | |
| Drug | Benperidol [2062-84-2]; Down 200; 10.4uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 4781_DN | |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 2240_DN | |
| Drug | Chicago sky blue 6B [2610-05-1]; Up 200; 4uM; MCF7; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 4971_UP | |
| Drug | Pirenzepine dihydrochloride [29868-97-1]; Down 200; 9.4uM; PC3; HT_HG-U133A | 2.12e-04 | 195 | 99 | 6 | 2071_DN | |
| Drug | Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 2236_DN | |
| Drug | Dienestrol [84-17-3]; Down 200; 15uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 3448_DN | |
| Drug | Paclitaxel [33069-62-4]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 5320_UP | |
| Drug | Disopyramide [3737-09-5]; Up 200; 11.8uM; PC3; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 7276_UP | |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Up 200; 9.4uM; HL60; HG-U133A | 2.17e-04 | 196 | 99 | 6 | 1586_UP | |
| Drug | Mefenamic acid [61-68-7]; Up 200; 16.6uM; PC3; HT_HG-U133A | 2.17e-04 | 196 | 99 | 6 | 5109_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; HL60; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 2559_DN | |
| Drug | Cyproheptadine hydrochloride [969-33-5]; Down 200; 12.4uM; PC3; HG-U133A | 2.23e-04 | 197 | 99 | 6 | 1938_DN | |
| Drug | rofecoxib; Down 200; 10uM; HL60; HG-U133A | 2.23e-04 | 197 | 99 | 6 | 371_DN | |
| Drug | Folinic acid calcium salt [6035-45-6]; Up 200; 7.8uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3442_UP | |
| Drug | Amodiaquin dihydrochloride dihydrate [6398-98-7]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 3186_DN | |
| Drug | Demeclocycline hydrochloride [64-73-3]; Down 200; 8uM; HL60; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 2545_DN | |
| Drug | Leucomisine [17946-87-1]; Down 200; 16.2uM; HL60; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 6125_DN | |
| Drug | Oleandomycin phosphate [7060-74-4]; Down 200; 5uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 1518_DN | |
| Drug | Betahistine mesylate [54856-23-4]; Down 200; 17.2uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 6611_DN | |
| Drug | Dubinidine [22964-77-8]; Up 200; 14.6uM; HL60; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 6131_UP | |
| Drug | Mexiletine hydrochloride [5370-01-4]; Down 200; 18.6uM; MCF7; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 2324_DN | |
| Drug | Idoxuridine [54-42-2]; Down 200; 11.2uM; PC3; HG-U133A | 2.23e-04 | 197 | 99 | 6 | 1899_DN | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; PC3; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 5746_DN | |
| Drug | Flumequine [42835-25-6]; Up 200; 15.4uM; HL60; HG-U133A | 2.23e-04 | 197 | 99 | 6 | 1429_UP | |
| Drug | Seneciphylline [480-81-9]; Up 200; 12uM; HL60; HT_HG-U133A | 2.23e-04 | 197 | 99 | 6 | 2140_UP | |
| Disease | neutrophil percentage of leukocytes | MARK3 SPTA1 ZC3H18 ITPKA RTF1 ZC3H7A GTF3C1 AKAP13 AKAP11 HTT DNMT3A | 4.38e-06 | 610 | 95 | 11 | EFO_0007990 |
| Disease | Craniofacial Abnormalities | 1.17e-05 | 156 | 95 | 6 | C0376634 | |
| Disease | coronary artery disease | ARHGAP42 SLK TCF7L2 CDK12 MARK3 SPECC1L ITPKA RTF1 ZKSCAN1 UHRF1 AKAP13 PLEKHH2 PALLD TNS3 | 2.80e-05 | 1194 | 95 | 14 | EFO_0001645 |
| Disease | Glioblastoma Multiforme | 3.04e-05 | 111 | 95 | 5 | C1621958 | |
| Disease | intellectual disability (implicated_via_orthology) | 1.03e-04 | 75 | 95 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Glioblastoma | 1.26e-04 | 79 | 95 | 4 | C0017636 | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 1.53e-04 | 6 | 95 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | Giant Cell Glioblastoma | 1.60e-04 | 84 | 95 | 4 | C0334588 | |
| Disease | hair colour measurement | ARHGAP42 TBC1D30 MARK3 ZC3H18 LYST ZNF276 TBC1D22A SYNE2 AKAP13 | 1.67e-04 | 615 | 95 | 9 | EFO_0007822 |
| Disease | hepatocyte growth factor activator measurement | 2.13e-04 | 7 | 95 | 2 | EFO_0008152 | |
| Disease | lethal congenital contracture syndrome (is_implicated_in) | 2.13e-04 | 7 | 95 | 2 | DOID:0060558 (is_implicated_in) | |
| Disease | hepatocyte growth factor measurement | 3.89e-04 | 44 | 95 | 3 | EFO_0006903 | |
| Disease | information processing speed, cognitive function measurement | 4.54e-04 | 10 | 95 | 2 | EFO_0004363, EFO_0008354 | |
| Disease | neutrophil count | PRUNE2 LIMA1 ITPKA ADGRG6 RTF1 ZC3H7A GTF3C1 IQSEC1 UHRF1 AKAP13 AKAP11 TNS3 HTT | 4.82e-04 | 1382 | 95 | 13 | EFO_0004833 |
| Disease | red blood cell density measurement | 5.43e-04 | 880 | 95 | 10 | EFO_0007978 | |
| Disease | Pancreatic Ductal Adenocarcinoma | 5.54e-04 | 11 | 95 | 2 | C1335302 | |
| Disease | platelet component distribution width | 7.42e-04 | 755 | 95 | 9 | EFO_0007984 | |
| Disease | cutaneous melanoma, hair color | 1.07e-03 | 62 | 95 | 3 | EFO_0000389, EFO_0003924 | |
| Disease | aspartate aminotransferase to alanine aminotransferase ratio | 1.07e-03 | 239 | 95 | 5 | EFO_0010934 | |
| Disease | obsolete_red blood cell distribution width | ARHGAP42 CDK12 MARK3 SPTA1 BACH1 HIP1R ZKSCAN1 ATAD2B SYNE2 PCIF1 AKAP13 ANKRD12 | 1.29e-03 | 1347 | 95 | 12 | EFO_0005192 |
| Disease | Eye Abnormalities | 1.35e-03 | 17 | 95 | 2 | C0015393 | |
| Disease | apolipoprotein B measurement | 1.36e-03 | 663 | 95 | 8 | EFO_0004615 | |
| Disease | gait measurement | 1.43e-03 | 150 | 95 | 4 | EFO_0007680 | |
| Disease | lean body mass | 1.44e-03 | 379 | 95 | 6 | EFO_0004995 | |
| Disease | mean platelet volume | CDK12 SPTA1 HIP1R MSANTD1 SYTL4 ATAD2B SYNE2 PROSER2 PLEC HTT | 1.66e-03 | 1020 | 95 | 10 | EFO_0004584 |
| Disease | pulse pressure measurement | ARHGAP42 TCF7L2 MARK3 RYK ADRA1B ATAD2B MYPN UHRF1 AKAP13 CDK11B PALLD TNS3 | 1.70e-03 | 1392 | 95 | 12 | EFO_0005763 |
| Disease | birth weight | 1.86e-03 | 399 | 95 | 6 | EFO_0004344 | |
| Disease | urinary microalbumin measurement | 1.88e-03 | 20 | 95 | 2 | EFO_0010967 | |
| Disease | waist-hip ratio | PRUNE2 TCF7L2 DUSP6 HIP1R YTHDC2 CEP192 TBC1D22A SYNE2 HTT PML DNMT3A | 1.95e-03 | 1226 | 95 | 11 | EFO_0004343 |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 2.07e-03 | 166 | 95 | 4 | EFO_0004530, EFO_0004611 | |
| Disease | Ovarian Serous Adenocarcinoma | 2.48e-03 | 23 | 95 | 2 | C1335177 | |
| Disease | Dwarfism | 2.93e-03 | 25 | 95 | 2 | C0013336 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KRDSSDQVESLASRD | 211 | Q8N715 | |
| REDSSVASSDRSSVE | 376 | O14867 | |
| RISGSSKRSNEETDD | 146 | Q9NYV4 | |
| DTSSSAAEREEDRKD | 11 | Q9Y6K1 | |
| SSSNFTDRDDKILTR | 1701 | Q86UK0 | |
| SSDSDLLESSSEALK | 641 | Q86SQ4 | |
| AETETSRSREESADA | 566 | Q12802 | |
| SDDSESIEESDTRRK | 136 | Q71F23 | |
| ESAKTLSVSRRSSEE | 936 | Q69YQ0 | |
| KAERELSSTSLAADS | 1661 | Q9UKA4 | |
| SLERSQSRKDSLDDS | 396 | P35368 | |
| SDSEKRSLDSRGETT | 656 | Q99490 | |
| RSDVETATDSDTESR | 731 | Q9P1A6 | |
| DISDSERKTSSAESS | 281 | P21127 | |
| ERKTSSAESSSAESG | 286 | P21127 | |
| LDSQSDDSKTSVRDR | 1966 | Q6UB98 | |
| LLTRKADSSSSEEES | 416 | Q14978 | |
| DEDSVAGSSRESTRK | 176 | O00763 | |
| RFEDDRSDSSSSLLS | 181 | Q6ZTZ1 | |
| SERSDNRSEASERSD | 81 | Q8WVC0 | |
| LSSSTFDSEKNESRR | 241 | Q9UHB6 | |
| EESSTSRKRTTEDDI | 141 | O15151 | |
| DTTSSDEERFERRKS | 336 | Q9ULI0 | |
| SDSSVDLSDRSERGS | 386 | Q6DN90 | |
| GRRDDSLSSTSEDSE | 3716 | Q2LD37 | |
| RKSRKRVDSDSDSDS | 2501 | Q6KC79 | |
| SRRASESSLSSESSE | 91 | P30305 | |
| DSLASERDRLTSKEE | 621 | Q86UP2 | |
| SDLERALTESKETAS | 1126 | Q9UGL1 | |
| RRQDDIKDESSEFSS | 486 | Q9Y5B6 | |
| EEDSSRSSSRTSESD | 626 | Q8IVE3 | |
| EKELSDSVTLSSSDR | 1226 | O75694 | |
| SSRLSSDLTRETDEA | 1621 | Q7Z6E9 | |
| DSEDDLLSDSESRSR | 136 | P23677 | |
| STDSDSESLAFKSRA | 366 | Q8WX93 | |
| ASRSSSAASSDDERE | 51 | Q8N414 | |
| SDKESVRTSLALDES | 221 | Q86U42 | |
| RSSVDLEESSTKSLE | 536 | Q8NFC6 | |
| SDDAERKQERETFSS | 876 | P46100 | |
| RRKVSSEDSEDSDFQ | 1371 | P46100 | |
| SKSELSSRLDTLSAE | 541 | O75146 | |
| SSRLDTLSAEKDALS | 546 | O75146 | |
| LEDDSESRSDVSSSA | 451 | P42858 | |
| SSSSEAKDRDSGREQ | 681 | Q9H4Z3 | |
| RSDRKSESYSESSSD | 846 | Q9NSI6 | |
| TSGDSSDSAESSERR | 1501 | Q9NSI6 | |
| SSSEESKESSRARES | 1546 | Q9NSI6 | |
| RDARKTQLSTSDSEA | 156 | Q99698 | |
| RKSSELDASDSSSSS | 366 | P27448 | |
| RKSRSTSDLDKDDAS | 561 | Q8TEP8 | |
| RISSDSSSDIESDLD | 171 | Q16828 | |
| KRIELDDSISASSSS | 256 | P34925 | |
| DSDSDLSSSSLEDRL | 211 | Q9UNE2 | |
| DDKSSEKSDRSSRTS | 321 | Q92541 | |
| EKSDRSSRTSSSDEE | 326 | Q92541 | |
| KRRKDSSEESDSSEE | 336 | P35269 | |
| SLDSFTADSDSTSRR | 201 | Q96C24 | |
| TADSDSTSRRDSLDK | 206 | Q96C24 | |
| SSDRQLSESSTKDSL | 376 | Q6WKZ4 | |
| SDTSESSAAEFDDRR | 421 | O94763 | |
| SKRASSDLSIASSEE | 336 | Q9H2G2 | |
| SRSSKESSVFLSDDS | 436 | Q8WUY3 | |
| RITSDFSSEEDRSSS | 1136 | Q8WXH0 | |
| RSSSEESDSDREALA | 476 | Q13428 | |
| ERSDTNEKRSVDSSA | 261 | P30414 | |
| RSSEVSKDSSTSLDA | 111 | Q8NFW8 | |
| SSSREDATKTDAESD | 686 | A6NI28 | |
| SSSSRSRSFTLDDES | 36 | Q86WR7 | |
| ESESSTSDDKRASLD | 326 | Q7Z6M4 | |
| SSRELDDSSSESSDL | 571 | P29590 | |
| SENKSEDLSSERTSR | 1231 | Q562F6 | |
| ARRLDEKESSEDKSS | 671 | Q5T8A7 | |
| STASARTDKTEERLA | 396 | Q68CZ2 | |
| SETSDDDSESRRRLD | 541 | Q9NRH2 | |
| SSRGSLDSSRSEKDR | 836 | P25054 | |
| RQKRSDSVSTSDEDS | 131 | Q9NZR4 | |
| ESSTEETDKSRERSQ | 1221 | Q8NI27 | |
| VLDSTKSSRESSEAR | 96 | P47985 | |
| RDRKSSDSDSSDSES | 196 | Q9NP64 | |
| DTKASDVDTSSSTLR | 2521 | Q96T58 | |
| SDSSLLGKRLSEDSS | 26 | Q9NYP9 | |
| RDCSKSSSRDTSSSE | 91 | Q9NW82 | |
| TSSDKDLRSNSERDL | 791 | Q6ZQQ2 | |
| RSQSREDSNSSSEKS | 301 | Q9NYB5 | |
| RSESFRDKSRESLEE | 71 | Q9NQB0 | |
| RDSIHRTESEESSKD | 171 | Q8N9M5 | |
| STSDDRVKDEFSDLS | 346 | Q8N554 | |
| KDLSRSSDSEEAFET | 1941 | O95359 | |
| RRDSLDSSTEASGSD | 111 | Q9Y2I9 | |
| NSLRSDDKSSLDSLE | 1416 | P02549 | |
| ASKARAEEESRSTSE | 1906 | Q15149 | |
| SSSALSEREASRLDK | 186 | Q8WUA7 | |
| ERDSLSEQEESSSSR | 226 | B2RXF5 | |
| ESKRDLSTSTSREGT | 366 | Q8IWR0 | |
| HSTKERDSELSDTDS | 81 | Q96T88 | |
| DRSDQSSLKSTDSSS | 1246 | Q9H6S0 | |
| DTFSDSRSSDRETKH | 841 | Q9NS56 | |
| QSRDLEKRASSSASE | 161 | Q9UIW0 | |
| KESSRRSSFSSDDGD | 331 | O14948 | |
| ESTSKAETSEDSASR | 276 | P17029 | |
| FLSSTDASTRDSADR | 391 | Q64LD2 | |
| SESDSEEERSSSKRR | 476 | Q12789 | |
| KSRSRKDDDSLSEAS | 61 | Q8NDX6 | |
| RELDSSDRDISSATD | 486 | Q14679 | |
| SDSSRDDESKEAKST | 176 | Q99453 | |
| EDRTSDLRDEASSVT | 106 | Q86VM9 | |
| SSSFSDLSERRERSS | 196 | Q86TC9 |